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SUMMARY
Insertional mutagenesis has been used to investigate 
the functional role of the HSV-1 UL1 and UL2 gene products 
in the lytic cycle of the virus. The genes were mutagenised 
by disruption of the protein coding sequences, which was 
achieved by inserting a segment of foreign DNA into a 
plasmid-cloned copy of the target gene. The insert 
contained a marker gene, the Escherichia coli LacZ gene 
under the direction of the SVAO early promoter, and was 
tranferred into the wt genome by homologous recombination 
of the flanking sequences.
Recombinant progeny were isolated by the addition of X- 
gal, a chromogenic substrate for B-ga1actosidase (the 
product of the LacZ gene) to an agar overlay. Plaques of 
recombinant virus, which appear blue using this screening 
technique, were subjected to plaque purification.
This technique was used in attempts to construct three 
different recombinants. In all three cases, the co­
transfection gave rise to blue plaques, and in two cases 
the recombinants were purified. The first of these 
(designated inl601) carried the insert in the coding region 
of the gene UL2 as verified by restriction endonuclease 
analysis. Earlier mapping studies had indicated a possible 
function for the product of this gene, namely uracil-DNA 
giyc osylase, a DNA repair enzyme which appears to be 
ubiquitous. Enzyme assays performed on extracts of tissue 
culture cells infected with inl601 were consistent with 
this assignation, as they demonstrated that inl601-infected 
extracts had only mock-infected levels of uracil-DNA 
glycosylase activity, but wt levels of three other virus- 
induced enzymes. Final confirmation came with comparison 
between the amino acid sequence of the UL2 gene product and 
the amino acid sequences translated from other known 
uracil-DNA glycosylase genes (E . coli, Saccharomyces 
cerevisiae and human). Immunoblotting analysis, using
antisera raised against a synthetic oligopeptide 
representing the carboxy terminus of the protein, showed a 
reaction with a protein of approximate Mr 39,000, which is 
similar to enzymes from other sources.
The mutant was readily isolated and possesses growth 
characteristics very similar to wt, indicating that the 
enzyme does not appear to be required for lytic growth, at 
least in the tissue culture system employed for growth and 
maintenance of the recombinant. This is in contrast with 
the observations that a high degree of amino acid 
conservation exists between the enzymes from different 
sources, and that the gene is found in all of the 
herpesviruses sequenced to date. The latter would tend to 
imply an important role in vivo for this enzyme. It is 
accepted that this in vivo function is the removal of 
uracil from DNA, brought about by deamination of cytosine. 
This is a potentially mutagenic event, and if left 
uncorrected, would result in a G.C to A.T transition 
mutation.
The second recombinant which was purified was 
designated inl602 and was constructed by co—transfection of 
the mutated plasmid-borne copy of the UL2 gene with a virus 
containing an insertion in the gene encoding the virus 
induced dUTPase. This enzyme is thought to be responsible 
for minimising the misincorporation of dUTP into DNA during 
replication, by lowering the pool of dUTP. Although this 
also results in the presence of uracil in the DNA, it will 
not result in mutagenesis if left uncorrected, as 
subsequent replication will not alter the sequence of the 
DNA.
Misincorporation of dUTP into DNA and in situ 
deamination of cytosine are the two major mutagenic events 
which result in the presence of uracil in DNA. Therefore 
the recombinant inl602 is deficient in both of these genes,
as confirmed by restriction analysis, and in both of these 
activities, as confirmed by enzyme assays.
The third recombinant, whose construction was attempted 
unsuccessfully, represented insertion of the LacZ sequences 
into the coding sequence of the gene UL1. Although the 
initial co-transfection also yielded blue plaques, these 
failed to grow through subsequent rounds of plaque 
purification. The co-transfection was repeated twice and 
repeated attempts were made to titrate the blue plaques 
obtained from the co-transfection, all without success. 
Control experiments done in tandem with these titrations 
indicate that the procedure was functioning normally. The 
two most likely explanations for this phenomenon are: (a)
The recombinant was unstable due to other, unpredicted 
alterations to the genome. This has been observed in the 
construction of other recombinant viruses, but usually when 
the construction has involved duplication of virus DNA 
sequences, (b) There is a stringent requirement for the UL1 
gene product in the replicative cycle of the virus. At 
present there is no direct evidence which would support 
either of these explanations at the expense of the other.
Searches of amino acid sequence databases failed to 
identify any sequences which could be homologues of this 
protein, so there is no further functional information 
about this protein.
NON-STANDARD ABBREVIATIONS
A deoxyadeny1ic acid residue in DNA
AP apurinic/apyrimidinic
BHK baby hamster kidney cells
BSA bovine serum albumin
bp base pair(s)
C deoxycytidy1ic acid residue in DNA
C terminus carboxy terminus of a protein
CCV channel catfish virus
dAMP 2 *deoxyadenosine 5 *-monophosphate
dATP 2 ’deoxyadenosine 5 ’-triphosphate
dCTP 2 ’deoxycytidine 5 ’-triphosphate
dGMP 2'deoxyguanosine 5 ’-monophosphate
dGTP 2 *deoxyguanosine 5 ’-triphosphate
dTTP 2 ’deoxythymidine 5 *-triphosphate
dUMP 2 ’deoxyuridine 5 ’-monophosphate
dUTP 2 ’deoxyuridine 5 ’-triphosphate
DNase deoxyribonuclease
EBV Epstein-Barr virus
EDTA ethylene diaminetetra acetic acid
G deoxyguany1ic acid residue in DNA
HCMV human cytomegalovirus
HHV-6 human herpes virus 6
HSV-1 herpes simplex virus type-1
HSV-2 herpes simplex virus type-2
HVS herpesvirus saimiri
HVT herpesvirus of turkeys
kb kilobase(s)
kbp kilobase pairs
MDV Marek’s disease virus
Mr Relative molecular mass
mu map units
ORF open reading frame
pfu plaque-forming units
pi post-infection
PMSF phenylmethy1sulphony1 fluoride
RNase ribonuc1 ease
SDS sodium dodecylsulphate
T deoxythymidy1ic acid residue in DNA
TCA trichloroacetic acid
TK thymidine kinase
TEMED N,N,N’,N' tetramethyl ethylenediamine
tri s tri s(hydroxymethy1)aminomethane
ts temperature-sensitive
UV ultra-violet radiation
Vm w viral protein
VZV varicella-zoster virus
X-gal 5-bromo-4-chloro-3-indoly1 B-D- 
galactopyranoside
INTRODUCTION
11.1 OBJECTIVES
Now that the genome of herpes simplex virus type-1 
(HSV-1) has been sequenced in its entirety, the way is open 
for a systematic investigation of the functions of the 
genes encoded therein. The objective of the work described 
in this thesis was to investigate the functions of certain 
HSV-1 genes which had been previously uncharacterised. The 
route chosen for this investigation was that of insertional 
mutagenesis by homologous recombination with a plasmid 
carrying a marker gene inserted into the protein coding 
sequence of the target gene. The resulting recombinant 
viruses have been subjected to functional analysis and 
their deduced or proposed functions are discussed. The 
results are also discussed with respect to the evolutionary 
significance of these viruses.
This introduction comprises a short overview of the 
biology of the Herpesviridae family in general and of HSV-1 
in particular. This is followed by an account of the 
structure and organisation of the HSV-1 virion and the 
structure and regulation of the genome. Succeeding this is 
a brief account of some of the proteins involved in DNA 
metabolism and replication, after which is a brief 
discussion of the evolutionary relationships between 
HSV-1 and the other human herpesviruses. The final section 
begins with an introduction to mutagenesis in HSV-1, before 
moving on to a topic which is directly relevant to the work 
described later in this thesis, namely the occurrence of 
uracil in DNA and the role of uracil-DNA glycosylase in its 
remova1.
The field of herpesvirus virology is a diverse and 
rapidly advancing one. There is currently a large body of
2information available about the biology of HSV-1 and much 
of this information is remote from the theory and 
experimental work described in this thesis. For this 
reason, several areas of herpesvirus virology are not 
mentioned in this introduction or are discussed in a 
superficial manner. These areas include latency, 
transformation, pathogenesis and, to large extent, 
replication and regulation of gene expression.
1.2 CLASSIFICATION OF THE HERPESVIRIDAE
The family Herpesviridae is a large and diverse group 
of viruses which have a wide variety of hosts, from fish 
(e.g. channel catfish virus; CCV), birds (Marek’s disease 
virus; MDV) through many vertebrates to-humans (HSV-1) 
(reviewed in Roizman, 1982). All members of this family 
share certain physical characteristics. The virus particle 
is large, typically 120-200 nm in diameter; the viral 
capsid has a characteristic structure and is composed of 
150 hexameric capsomers and 12 pentameric capsomers 
arranged in an icosahedral fashion (Wildy et al., 1960; 
Schrag et al., 1989); the viruses replicate within the 
nuclei of infected cells. The genomes of herpesviruses are 
large linear duplex DNA molecules with Mr from 80 to 150 X 
106 (Honess and Watson, 1977) and are composed of unique 
and reiterated sequences.
1.3 HUMAN HERPESVIRUSES
Man is known to be the natural host for six 
herpesviruses; these are HSV-1, HSV— 2, varicella— zoster 
virus (VZV), Epstein-Barr virus (EBV), human 
cytomega1ovirus (HCMV) and human herpes virus type 6 (HHV- 
6, formerly known as human B-lymphotropic virus). The first
3five are relatively well-characterised with respect to 
biology and pathogenesis (Roizman, 1982; 1983; 1985;
Roizman and Lopez, 1985). In contrast, HHV-6 was only 
recently discovered (Salahuddin et al., 1986) and was first 
isolated from persons suffering from AIDS or other 
lymphopro1iferative disorders. It has only been associated 
with one disease condition, exanthem subitum (a transient 
childhood illness, presumed to represent the primary 
infection). There is growing evidence that the majority of 
adults have been exposed to it (Briggs et al., 1988). 
Recently, there has been a report of a seventh human 
herpesvirus, designated HHV-7 (Frenkel et al., 1990), but 
this is as yet uncorroborated.
Members of the family Herpesviridae are further 
classified according to certain biological characteristics 
such as site of latency and restriction of host cell. 
However, this classification is neither rigorous nor 
exhaustive. These subgroups are the Alpha-, Beta- and 
Gammaherpesvirinae (Roizman, 1982; Roizman et al., 1981)
1.3.1 ALPHAHERPESVIRINAE
Members of this sub-family (including HSV-1, HSV-2 and 
mostly , , , ,
VZV) are^neurotroplc viruses and generally have a short
replicative cycle, usually less than 24 hours. This sub­
family is characterised by variable host cell range, both 
in vitro and in vivo and primary infection is usually 
restricted to a mild epidermal or mucosal infection 
(usually small mucocutaneous lesions with HSV-1 and -2, and 
chicken pox with VZV). These viruses can persist in the 
central nervous system as a latent asymptomatic infection. 
The individual may then remain free of any clinical 
manifestation of the infection for months or even years,
4although there is generally periodic spontaneous 
reactivation of the virus, leading to further 
vesicular mucocutaneous lesions in the case of HSV-1 and 
-2, and shingles in the case of VZV.
1.3.2 BETAHERPESVIRINAE
Members of the Betaherpesvirinae (including HCMV) 
exhibit a restricted host cell range. Infection is 
widespread but is usually asymptomatic. However, infection 
can have serious or even life-threatening consequences in 
neonates or immunocompromised persons. In vitro, these 
viruses replicate best in fibroblasts but have a long 
replicative cycle, greater than 24 hours and infection 
often results in the formation of enlarged infected cells 
(cytomega1ia). The virus can establish a latent infection 
in secretory glands and lymphoreticu1ar cells. HCMV appears 
to be aetiologically implicated in the development of the 
European form of Kaposi’s sarcoma (Giraldo et al., 1975)
1.3.3 GAMMAHERPESVIRINAE
This sub-group includes E B V . Its members, like those of 
the Betaherpesvirinae, exhibit a restricted host cell range 
and have a tropism for lymphocytes. Although they all 
replicate in lymphoblastoid cells, the length of the 
replicative cycle varies between members. They often 
establish persistent, latent infections, and are capable of 
transforming lymphoblastoid cells in the process. EBV has a 
strong association with nasopharyngeal carcinoma and 
Burkitt’s lymphoma (Desgranges et al., 1975; de The, 1979).
51.4 BIOLOGY AND PATHOLOGY OF HERPES SIMPLEX VIRUS
Herpes simplex virus infection is typified by 
characteristic, vesicular lesions of the facial and genital 
mucosae. It is usually the case that infections which 
result in facial lesions, particularly around the mucosae 
of the mouth and nose, are caused by infection with HSV-1, 
and that infections leading to lesions around the genital 
mucosae are caused by HSV-2. However the two sites are not 
mutually exclusive for the respective viruses and 
increasing numbers of genital infections caused by HSV-1, 
and facial lesions as a result of HSV-2 infection, are 
being reported (Whitley, 1985). Most adults have been 
exposed to HSV-1 infection. Primary infection by HSV-1 
usually occurs in childhood but the clinical manifestations 
of this infection range from being asymptomatic to 
ulcerative, vesicular lesions and gingivostomatitis. HSV 
establishes a latent infection in the trigeminal ganglia 
and can spontaneously reactivate via sensory neurons to the 
skin, usually as the archetypal lip lesion - herpes 
labialis (Whitley, 1985).
Although all of the clinical conditions described so 
far have not been of life-threatening severity, HSV is also 
responsible for a number of serious conditions, although 
these do not occur with the same frequency as the less 
serious conditions described so far. The more hazardous 
complications include herpes simplex induced acute 
necrotising encephalitis, eczema herpeticum and 
keratoconjunctivitis, which can lead to corneal blindness 
(Whitley, 1985). Also, the implications of HSV infection in 
immunocompromised individuals and neonates are far more 
serious (Rawls, 1973). HSV— 2 infection has also been 
implicated in the aetiology of at least a proportion of
6cases of cervical carcinoma (Naib et al., 1966; Aurelian et 
al., 1973; McDougall et al., 1980; Eglin et al., 1981; Park 
et al., 1983), although its precise role in the 
transformation process is not clear (zur Hausen, 1982; 
Galloway and McDougall, 1983; Rawls, 1985).
1.5 STRUCTURE OF THE HSV VIRION
The herpesvirus virion is a complex structure which can 
be regarded as being composed of four concentric layers 
(Hay et.al, 1987). These layers are the core, capsid, 
tegument and envelope. The virus DNA is to be found in the 
core, which is at the centre of the virion (Hay et al., 
1987). Recently, Schrag et al. (1989) have examined the 
HSV-1 nucleocapsid by computer analysis of low dose cryo- 
electron images of ice-embedded capsids. Using this 
technique, the authors have resolved the three-dimensional 
structure of the nucleocapsid. This is the first analysis 
where the structure has been determined directly as opposed 
to being inferred. It is proposed that the nucleocapsid is 
organised into at least three distinct structural layers, 
designated the outer, intermediate and inner shells (Schrag 
et al., 1989).
The outer shell is defined as the mass between the 
radii of 425 A and 625 A. The study by Schrag et al. (1989) 
indicates three major structural features associated with 
the outer shell. The first of these consists of six- 
coordinated capsomers which appear to be hexagonal and to 
interact with connecting proteins. Predictions of capsomer 
masses are consistent with the nomination of VP5 as the 
capsomer protein (Weller et al., 1987) and confirm studies 
which demonstrated the six-fold symmetry of these capsomers 
(Furlong, 1978; Steven et al., 1986). The second structural
7feature of the outer shell is the presence of twelve 
capsomers residing on the icosahedral five-fold positions, 
which Schrag et al. (1989) have postulated are also 
composed of the virion protein V P 5 . The third structural 
feature is the presence of a mass density connecting 
adjacent capsomers. Surface labelling studies by Braun et 
al. (1984) demonstrated that VP23, a protein of Mr 36,000, 
is located on the outer capsid surface and therefore may 
comprise the capsomer connections.
The intermediate shell is described as the mass between 
the radii of 310 A and 425 A. It is proposed that the 
density between these radii represents a single structural 
layer. There are two lines of evidence which suggest this 
layer is composed of protein. Studies by Cook and Stevens 
(1970) showed that this layer in VZV sections was 
unaffected by DNase treatment and remained adhered to the 
inner capsid surface. Secondly, it is known that HSV-1 
nucleocapsid assembly is a multi-stage process, and there 
are several stages in which internal proteinaceous 
structures are seen within the capsid. These "partial 
cores" are heterogeneous in both size and appearance, ts 
mutants of HSV-1 which fail to package DNA at the non- 
permissive temperature also produce these partially cored 
structures and it has been been suggested that they are 
part of the normal assembly process (Schaffer et al., 1974; 
Preston et al., 1983). These capsids do not contain DNA and 
so it is thought that this layer must be composed of 
protein. The reconstruction data of Schrag et al. (1989) 
suggest that the underlying lattice of this layer has T=4 
icosahedral symmetry, although the composition of this 
layer is at present a matter for debate. It has been 
suggested that VP21, a protein of Mr 45,000, is the major 
component of the core (Gibson and Roizman, 1972) but this
8has since been disputed (Braun et al., 1984). Further 
studies are required to establish the composition of the 
T=4 protein shell.
The mass density below the radius of 310 A is proposed 
to contain the genomic DNA. Although the structural 
organisation of this region could not be resolved by Schrag 
et al. (1989), they were able to accurately calculate the 
average mass density. The calculated dry mass is 2.13 x 10- 
16 g, which is large enough to accommodate some protein as 
well as the DNA.
Surrounding the capsid is a layer of amorphous 
proteinaceous material known as the tegument (Roizman and 
Furlong, 1974). The diameter of this layer is variable and 
its function is not known at present.
The outermost layer of the virion is a lipid bilayer 
known as the envelope (Wildy et al., 1960). The envelope is 
derived from the nuclear membrane and is studded with at 
least seven structural glycoproteins (namely gB, g C , gD, 
g E , gG, gH and gl) which are virus encoded (Buckmaster et 
al., 1984; Spear, 1985; Frame et al., 1986; McGeoch and 
Davison, 1986; Longnecker et al., 1987).
1.6 STRUCTURE OF THE HSV GENOME
The genome of HSV-1 strain 17, as isolated from 
virions, is composed of a single, linear molecule of double 
stranded DNA, containing 152,260 bases in each strand 
(McGeoch et al., 1985; McGeoch et al., 1986, McGeoch et 
al., 1988; Perry and McGeoch, 1988). However HSV-1, like 
all herpesviruses studied, exhibits heterogeneity between 
strains and so this number refers only to the isolate which
9has been sequenced. Genomic HSV DNA is unmethylated (Low et 
al., 1969) and HSV-1 has a base composition of 68.3% G+C 
(McGeoch et al., 1988). The G+C content is not uniform 
throughout the genome; the short repeat region, for 
example, has a base composition of 79.5% G+C (McGeoch et 
al., 1986) and the short unique region is 64.3% G+C 
(McGeoch et al., 1985). There is a single unpaired residue 
at each 3 s terminus (Mocarski and Roizman, 1982). It is 
proposed that HSV-1 genome contains at least 72 distinct 
genes (McGeoch et al. 1988), although there are known to be 
two copies of two genes. The locations of all the proposed 
genes are depicted in figure 1.1.
HSV DNA is regarded as being composed of two segments, 
designated the long (L), and the short (S) regions, which 
are covalently joined (Delius and Clements, 1976; Roizman, 
1979). Both of these segments are composed of unique 
sequences (Ul and Us respectively) bounded by inverted 
repeat sequences. Thus, L is composed of Ul which is 
flanked by inverted repeat sequences at the terminus (TRl ) 
and the joint (IRl ). Similarly, S is composed of Us, TRs 
and IRs• The sequences of Rl and Rs are distinct, with the 
exception of a 400 bp direct repeat, designated the a 
sequence, at the genome termini. There is one copy of this 
redundancy at the S terminus and variable numbers of it at 
the L terminus. It is also present, again in variable copy 
numbers and this time inverted with respect to the terminal 
a sequences, at the L\S joint (Wagner and Summers, 1978). 
The redundant sequence in TRl and IRl, excluding the a 
sequence, is known as the b sequence. Similarly, the short 
repeat regions are composed of an a and a c sequence 
(Roizman, 1979). The overall arrangement of the HSV-1 
genome is shown diagrammatica1ly in figure 1.2, and in 
figure 1.3 it is compared with the genomes of other human

Figure 1.2 : Structure of the HSV-1 genome
The figure depicts the genome of HSV-1, with the 
solid lines representing unique sequences, and the open 
boxes representing the repeated sequences. The positions 
of the a, b and c sequences are indicated, as are their 
respective inverted repeated units a*, b’ and c ’ . The 
upper scale bar is in map units (mu).
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Figure 1.3 : Layouts of human herpesvirus genomes
The genomic layouts of HSV-1, HSV-2, V Z V , EBV and 
HCMV. As before, unique sequences are denoted by solid 
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herpesviruses.
1.6.1 ISOMERISATION OF THE HERPES SIMPLEX VIRUS GENOME
Because the sequences found at the termini are repeated 
internally, Sheldrick and Berthelot (1974) suggested that 
recombination between these sequences might be possible.
The result of this would be inversion of the L or S 
segments with respect to each other, producing four 
sequence-orientation isomers. The existence of four such 
isomers was subsequently demonstrated, by restriction 
enzyme analysis (Hayward et al., 1975; Clements et al., 
1976) and partial denaturing mapping of heteroduplex DNA 
(Delius and Clements, 1976). DNA extracted from wt virions 
is composed of all four isomers in equimolar amounts and 
all four are equally viable in terms of growth and 
replication (Davison and Wilkie, 1981). The isomers are 
termed P (Prototype), II (L inverted with respect to P ) , Is 
(S inverted with respect to P) and Isl (Both S and L 
inverted with respect to P) (Roizman et al., 1979). The 
four isomers are depicted in figure 1.4. Studies on 
intertypic recombination between HSV-1 and -2 demonstrated 
that inversion has an absolute requirement for the a 
sequences, with those at the L terminus and the L\S joint 
being sufficient to mediate inversion (Davison and Wilkie, 
1983b). Mutagenesis studies have shown that deletion of the 
L\S joint a sequence abolishes inversion, which can be 
restored by insertion of additional copies (Poffenberger et 
al., 1983; Mocarski et al., 1980).
1.6.2 HERPES SIMPLEX VIRUS DNA REPLICATION
HSV DNA replication is one process in the infective 
cycle which at present is incompletely characterised. It is
Figure 1.4 : Sequence orientation isomers
The four sequence orientation isomers of HSV-1 are 
shown. The arrows refer to the relative orientations of 
the L and S segments in the isomers. The nomenclature is 
as follows;
P Prototypic orientation
II L inverted (with respect to P)
Is S inverted
Is l  L and S inverted
li
V
□ 0
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known that virus DNA accumulates in the nucleus of cells 
after infection, where it appears to circularise. This 
circularisation may be as a result of direct ligation of 
the termini (Poffenberger and Roizman, 1985), possibly 
mediated by the complementary unpaired residues present at 
the 3 ’ termini of the genome (Mocarski and Roizman, 1982). 
Electron microscopic studies have revealed the presence of 
"large tangled masses" of replicating DNA (Hirsch et al., 
1977; Jacob and Roizman, 1977). It has been demonstrated 
that, late in infection, virus DNA is found in a form which 
sediments rapidly and has a low relative abundance of 
termini (Jacob et al., 1979; Jongeneel and Bachenheimer, 
1981). It is accepted that virus DNA replication is by a 
rolling circle mechanism, as long head to tail concatemers 
are found late in infection (Stow et al., 1983; Stow,
1985). Cleavage of concatemeric DNA into unit lengths is 
possibly mediated by site-specific signals found in the a 
sequence (Davison and Wilkie, 1981; Varmuza et al., 1985). 
Cleavage of the DNA is thought to be coupled to 
encapsidation (Deiss and Frenkel, 1986), and the cis-acting 
signals responsible for both events are all believed to be 
within the a sequence (Stow et al., 1986).
Studies using defective virus DNA (Frenkel et al.,
1975; Kaerner et al., 1979) and electron microscopy 
(Friedmann et al., 1977; Hirsch et al., 1977) suggested the 
presence of at least two distinct cis-acting signals which 
could mediate HSV DNA replication: one located near the 
centre of Ul (OriL) and another in both copies of Rs (Oris) 
and therefore diploid. Direct evidence that both of these 
sites contain a functional origin of DNA replication was 
tendered by demonstration that monomeric defective virus 
DNA could be amplified by cotransfection with wt helper 
virus, yielding head to tail concatemers of the defective
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virus DNA (Vlazny and Frenkel, 1982; Spaete and Frenkel, 
1982; Spaete and Frenkel, 1985). The origins were more 
finely mapped using plasmid-borne helper DNA to rescue the 
defect (Mocarski and Roizman, 1982; Stow, 1982; Weller et 
al., 1985). Both origins have subsequently been sequenced 
(Gray and Kaerner, 1984; Whitton and Clements, 1984; Quinn 
and McGeoch, 1985; Weller et al., 1985). Genomic analysis 
of the origins has demonstrated that both lie between two 
divergently transcribed genes. Orii, lies between 
the 5 ’ ends of the early genes UL29 and UL30 which encode 
the major DNA-binding protein and the DNA polymerase, 
respectively. Each copy of Oris lies between the 5 ’ ends of 
two IE genes, IE175 and US1 in the case of IRs and between 
IE175 and US12 in the case of T R s . Whether or not this has 
implications for replication or transcription is not known. 
The individual proteins involved in virus DNA replication 
(both directly and indirectly) are discussed separately.
1.7 STRUCTURE AND ORGANISATION OF HSV GENES
The synthesis and processing of virus-specific RNAs is 
similar to that of cellular RNA. HSV DNA is transcribed in 
the nucleus of the infected cell (Wagner and Roizman,
1969). Host encoded RNA polymerase II is utilised 
throughout infection (Alwine et al., 1974; Ben-Zeeve and 
Becker, 1977; Costanzo et al., 1977). The RNAs are capped 
at their 5* ends and internally methylated in a manner 
similar to host cell transcripts (Bartkoski and Roizman, 
1976; Moss et al., 1977). Most virus RNAs are 
polyadeny1ated at their 3 ’ ends (Bachenheimer and Roizman, 
1972).
It is, therefore, not surprising that most HSV genes 
possess upstream and downstream regulatory regions similar
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to those of the host cell genes (McKnight, 1980; Frink et 
al., 1981; Everett, 1983; Preston et al., 1984; Rixon et 
al., 1984; Rixon and McGeoch, 1985). These include the 5 ’ 
promoter sequences such as the ’TATA’ box and 1CAAT* box 
motifs (Gannon et al., 1979; Wasylyk et al., 1980; Benoist 
et al., 1980; Efstratiadis et al., 1980) and the 3 ’ pre- 
mRNA c 1eavage/polyadeny1 ation signal, ’AATAAA’ (Proudfoot 
and Brownlee, 1974, 1976; Fitzgerald and Shenk, 1981;
Zarkower et al., 1986). A number of HSV genes have a 
discernible ’TA TA’ box motif situated between 25-30 bp 
upstream of the translational start site of the gene 
(Corden et al., 1980; McGeoch et al., 1985). The sequence 
AATAAA or a close variant, ATTAAA has been found near the 
3 ’ termini of all HSV mRNAs mapped (McGeoch et al., 1985). 
There is another motif, the ’YGTGTTYY’ sequence, which is 
found downstream from the polyadenylation signal in a 
number of eukaryotic genes (Taya et al., 1982; McLauchlan 
and Clements, 1983) and has subsequently been shown to be 
required for efficient processing of the 3 ’ termini of 
mRNAs. This motif has been discovered in many HSV genes 
(McLauchlan et al., 1985).
One aspect of gene structure which differs markedly 
from the situation in the host cell is the degree of 
splicing. Splicing is a relatively uncommon event in HSV 
gene organisation (Wagner, 1985) and only a few split genes 
are known (Watson et al., 1981; Rixon and Clements, 1982; 
Frink et al., 1983; Costa et al., 1985; Perry et al.,
1986).
The genome of HSV-1 has been fully sequenced and the 
genetic organisation has been analysed (McGeoch et al., 
1985; 1986; 1988; Perry and McGeoch, 1988). It is proposed
that there are 56 genes in Ul (designated UL1 to UL56), 12
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in Us (US1 to US12) and one in each copy of Rl and Rs , 
making a total of 72 genes encoding 70 distinct proteins 
(the genes present in the repeats being diploid). Although 
this analysis is extensive it is accepted as being open to 
augmentation. Indeed there has been a published report of 
another gene in Rl , upstream of IE110 (Chou and Roizman,
1986), but this assignment has been disputed (Perry and 
McGeoch, 1988). In general, the genetic organisation of 
HSV-1 is regarded as being compact but not unduly 
compressed. However, there is a region in both long repeat 
elements between the 3' end of IE110 and U l » of 
approximately 3500 bp, whose functional potential is 
obscure. It has been demonstrated that part of this region 
is transcribed, most abundantly in latently infected 
neurons (Stevens et al., 1987; Rock et al., 1987; Spivack 
and Fraser, 1977). The transcript which initiates here is 
the latency associated transcript or LAT, and it is thought 
not to be translated into a protein product. Certainly no 
such protein has yet been elucidated and analysis of the 
proposed transcript does not support its existence (Perry 
and McGeoch, 1988; Wagner et al., 1988).
1.8 REGULATION OF HSV GENE EXPRESSION
The expression of HSV genes is tightly regulated and 
systematically ordered in a sequential pattern. There are 
three broad groupings of genes. These are the immediate- 
early (IE) genes, the early (E) genes and the late (L) 
genes. Each of these is briefly discussed in turn.
1.8.1 IMMEDIATE-EARLY GENE EXPRESSION
The first genes to be expressed are the five IE genes 
(Watson et al., 1979). Expression of these genes is
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independent of de novo protein synthesis in newly-infected 
cells (Honess and Roizman, 1974; Harris-Hami1ton and 
Bachenheimer, 1985). The five IE genes are located at or 
close to the inverted repeats, as shown in figure 1.5 
(Clements et al., 1979; Watson et al., 1979; Anderson et 
al., 1980; Watson et al., 1981).
Although the IE genes are expressed immediately upon 
infection of the cell, their expression is subject to 
virion-mediated modulation (Batterson and Roizman, 1983). 
The product of gene UL48 (Vmw65, a major component of the 
tegument) has been to shown to augment IE gene expression 
from basal levels (Campbell et al., 1984). This stimulation 
is specific to IE gene promoters (O’Hare and Hayward,
1985). IE gene expression is also controlled by a number of 
other virus genes. There is positive-feedback from 
expression of IE110, the product of IE gene 1 (O’Hare and 
Hayward, 1985) and down-regulation by IE175, the product of 
IE gene 3 (Preston, 1979). O ’Hare and Hayward (1985) 
proposed that the overall level of IE gene expression may 
be controlled by the relative abundance of these two IE 
proteins.
It has been been known for some years that sequences 
upstream of the mRNA cap sites are important for control of 
IE gene expression (Post et al., 1981; Mackem and Roizman, 
1982a). There are sequence data available for the upstream 
regulatory regions of all five IE genes (Murchie and 
McGeoch, 1982; Mackem and Roizman, 1982a; 1982b; Whitton et 
al., 1983). A highly conserved sequence motif is present in 
one or more copies, upstream of all IE genes (Mackem and 
Roizman, 1982b; Preston et al., 1984). This sequence has 
the consensus 5 ’-TAATGARATTC-3’ (where R = a purinic 
residue) and is conserved in HSV—2 (Whitton et al., 1983;
Figure 1.5 : HSV-1 IE genes
The locations and orientations of the five IE genes 
are shown.
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Whitton and Clements, 1984). Preston et al. (1984) 
demonstrated that this motif, which appears to be unique to 
IE genes, is crucial for stimulation of IE transcription by 
Vmw65. The conservation of this motif between all the IE 
genes and across the two serotypes is indicative of its 
importance in the regulation of IE gene expression.
1.8.2 EARLY GENE EXPRESSION
The next genes to be expressed are the E genes (Wagner 
et al., 1972). A scheme of nomenclature has been proposed, 
whereby E genes are subdivided into two groups, p\ and ^ 2 » 
according to the time they are first expressed (Mavromara- 
Nazos et al., 1986). Like the IE genes, the E genes are 
subject to regulatory control by a number of factors.
IE175, as well as being responsible for repression of IE 
genes, also has a role in the activation of E gene 
expression (Watson and Clements, 1980). By itself, IE175 is 
capable of inducing E gene expression in short term 
transfection assays (Everett, 1984a). This induction 
appears to be specific and involves cis-acting sequences in 
the upstream regulatory region.
Short term transfection assays were also used to 
demonstrate that IE110 can independently stimulate E gene 
expression (O'Hare and Hayward, 1985). Transactivation by 
IE110 is less specific than that by VBW65 or IE175 
(Everett, 1984a) and is not present in all E genes. It is 
also the case that the level of transactivation of E genes 
by IE110 is variable (Gelman and Silverstein, 1985; O ’Hare 
and Hayward, 1985).
Up-regulation of E gene expression is markedly enhanced 
in transfection assays where the genes encoding both IE110
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and IE175 are co-transfected (Everett, 1984b; Quinlan and 
Knipe, 1985).
1.8.3 LATE GENE EXPRESSION
The last group of genes to expressed, at late times in 
infection, are the L genes (Wagner, 1972). Like the E 
genes, the L genes are divided into two groups; the leaky- 
late (^i) genes are expressed in the absence of virus DNA 
replication, and the true-late (^2 ) genes have a stringent 
requirement for virus DNA replication (Holland et al.,
1980) .
Although the promoters of the L genes are similar in 
structure to those of E genes, the former have additional 
requirements for expression (Wagner, 1985). In transfection 
assays, the regulation of L gene expression appears 
mediated only by IE175 and IE110, although it is not clear 
if any other IE gene products are involved. Virus DNA 
replication also plays a significant part in L gene 
activation (Hall et al., 1982; Johnson et al., 1986).
Watson and Clements (1980) proposed that IE175 is 
continuously required for transcription of L mRNAs. DeLuca 
et al. (1984) described a >.
ts mutant of IE175 which, at the non-permissive 
temperature, expressed IE and E genes to the same level as 
wt, and initiated DNA replication, but which synthesised 
greatly reduced levels of L proteins.
In short term transfection assays, IE110 is capable of 
enhancing expression from L gene promoters to the same 
extent as from E gene promoters (Mavromara—Nazos et al.,
1986) .
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1.9 HSV ENCODED PROTEINS
The genome of HSV-1 is thought to encode at least 70 
distinct polypeptides (McGeoch et al. 1988), although many 
more species can be detected by routine techniques. For 
example, Haarr and Marsden (1981) were able to detect at 
least 230 virus induced polypeptides by two dimensional 
electrophoretic analysis. It should be stated that among 
these are many processed species and so this impedes the 
enumeration of separate proteins. Amongst the first 
techniques employed in the functional analysis of distinct 
genes were the use of ts and drug resistant mutants. Marker 
rescue of thesemutationsfaci1itated the assignment of 
genomic locations of specific genes (for example, see Stow 
et al., 1978). At present, some sort of functional 
information is known for around 50 of the predicted genes 
but there are still aproximately 20 genes about which 
nothing is known (McGeoch, 1989). In general, HSV encoded 
proteins are loosely classified by many different criteria. 
Functional analysis organises the proteins into those 
involved in the structural integrity of the virion, those 
involved in processes of regulation and control and those 
associated with DNA replication and metabolism. Each of 
these groups is discussed in turn.
1.9.1 STRUCTURAL PROTEINS
The HSV virion is thought to contain 15-33 different 
structural polypeptides, including those of the 
nuc1eocapsid, the tegument and the glycoproteins located on 
the virion envelope (Spear and Roizman, 1980).
The rigid structure of the herpesvirus virion places 
architectural constraints on the size and number of
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proteins which make up the nuc1eocapsid. This is reflected 
in the striking similarity of the structural polypeptides 
from different herpesviruses (Dargan, 1986). The HSV-1 
nucleocapsid is considered to be composed of seven 
strucural proteins. Gibson and Roizman (1972) identified 
six of these, with Heilman et al. (1979) and Cohen et al. 
(1980) subsequently identifying the seventh.
Very little is known about the nature of the tegument, 
and this scarcity of knowledge extends to the polypeptides 
which make up this structure. It is estimated that there 
are approximately 15 non-glycosy1ated polypeptides which 
the virion acquires during envelopment (Dargan, 1986). Most 
of these have yet to be functionally characterised, 
although it is known that at least some of them are 
phosphory1ated in vivo (Gibson and Roizman, 1974). Spear 
and Roizman (1980) suggested that some of these are 
involved in envelopment, through interactions with the 
nucleocapsid and envelope proteins. One of the major 
tegument components is Vmw65, the product of gene UL48.
This protein is involved in transactivation of IE genes 
(Campbell et al., 1984), and has already been discussed.
The glycoproteins associated with the envelope are the 
most intensively studied of the structural proteins. In 
addition to their role as part of the envelope structure, 
HSV glycoproteins have been detected in both the nuclear 
and cytoplasmic membranes of infected cells (Spear et al.,
1970). HSV-1 is known to encode at least seven 
glycoproteins, namely, g B , g C , g D , g E , gG, gH and g l , which 
are the products of genes UL27, UL44, US6, US8, US4, UL22 
and US7, respectively (Spear, 1985; Frame et al, 1986; 
McGeoch and Davison, 1986; Buckmaster et al., 1984;
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Longnecker et al., 1987). All HSV-1 glycoproteins are known 
to have homologues in HSV-2 (Spear, 1985; Frame et al., 
1986; McGeoch et al., 1987; D. McGeoch, personal 
communication). In addition to their structural role, the 
g iy coproteins are thought to be involved in attachment and 
penetration of the host cell, in envelopment and budding of 
progeny virus particles and in the cell to cell spread of 
infection (Spear, 1985; Spear and Roizman, 1980).
1.9.2 PROTEINS INVOLVED IN CONTROL PROCESSES
Virus gene expression in HSV infected cells is subject 
to control at a variety of levels by a number of different 
proteins. These have already been discussed in section 1.8.
Many of the virus-encoded proteins are subject to post- 
translational modification, including phosphorylation, 
glycosy1 at ion and sulphation. These types of modification 
may alter the location or activity of proteins, both virus- 
encoded and host-derived. There are two HSV-1 genes, US3 
and UL13, which encode amino acid sequences with motifs 
characteristic of the protein kinase family and are 
proposed to encode species of protein kinase (Chee et al., 
1989; McGeoch and Davison, 1986; Smith and Smith, 1989).
The gene product of US3 has been identified as a protein 
kinase whose activity has been detected in infected cells, 
although its substrate has yet to be determined (Frame et 
al., 1987; Purves et al., 1987).
In addition to the proteins already mentioned, HSV also 
encodes a function which mediates the shutoff of host cell 
protein synthesis and degradation of host cell mRNA (Kwong 
et al., 1988). This is known as the virion host shutoff 
(vhs) function and is encoded by gene UL41.
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1.9.3 PROTEINS INVOLVED IN DNA REPLICATION
HSV encodes a number of proteins which are responsible 
for supplying the precursors for DNA replication (to be 
discussed separately) and for the replicative process 
itself. Among the latter are POL, the replicative DNA 
polymerase (Coen et al.f 1984), EXO, the alkaline 
exonuclease (Banks et al., 1983) and mDBP, the major, 
single-stranded DNA binding protein (Weller et al., 1983). 
It is known that these are not the only proteins required 
for replication of the viral genome and recently Challberg 
(1986) described a method for identifying those genes whose 
products are necessary for replication of HSV DNA. This was 
based on a short term transfection assay where a plasmid 
containing the cis-acting signals for replication was co­
transfected with other plasmids, which supplied the 
required trans-acting genes. Employing this technique, Wu 
et al. (1988) were able to identify a total of seven genes 
whose products were necessary and sufficient to facilitate 
replication of the plasmid containing the origin of DNA 
synthesis. In addition to POL and mDBP, they demonstrated 
the requirement for the products of the genes U L 5 , U L 8 ,
U L 9 , UL42 and UL52. The products of all these genes are 
discussed below.
i DNA POLYMERASE
The replicative DNA polymerase is encoded by the gene 
designated as UL30. The HSV-induced polymerase activity is 
associated with a polypeptide with Mr of 136K (Powell and 
Purifoy, 1977). It is known that the activity is distinct 
from the host-cell DNA polymerase both biochemically and 
immunologically (Keir et al., 1966b; Powell and Purifoy,
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1977; O'Donnell et al., 1987), that the protein is 
essential for virus replication (Purifoy et al., 1977) and 
that it has both polymerase and 3 ’ - 5 ’ exonuclease 
activities (Weissbach et al., 1973; Knopf, 1979). Recently, 
it has deen demonstrated that the POL gene product also 
contains an intrinsic ribonuclease H activity which 
specifically degrades duplex DNA or DNA/RNA heteroduplexes 
in the 5 ’ to 3 ’ direction (Crute and Lehman, 1989). It is 
proposed that this activity is analogous to the 5'-3' 
exonuclease activity associated with the DNA polymerase I 
of E. coli which is required for DNA repair and removal of 
RNA primers during replication (Kornberg, 1980). Although 
it has been shown to be active as a monomer in vitro 
(Knopf, 1979; Ostrander and Cheng, 1980), the HSV-2 DNA 
polymerase co-purifies with another protein, of Mr 55,000, 
now known to be the product of the gene UL42 and it is now 
considered that the holoenzyme is a heterodimer of the UL30 
and UL42 gene products (Vaughan et al., 1984; Parris et 
al., 1988).
A number of different types of polymerase mutants have 
been isolated; ts (for example Coen et al., 1974), drug 
resistance and drug hypersensitivity (Honess et al.,1984). 
The essentiality of the polymerase has made it a central 
target for antiviral agents, especially those which mimic 
dNTPs or pyrophosphate (for example acyc1oguanosine or 
phosphonoacetic acid), and resistance to such compounds can 
be due to a mutation in the polymerase gene (Hay and Subak- 
Sharpe, 1976; Chartrand et al., 1979; Crumpacker et al.,
1980; Coen et al., 1982; Honess et al., 1984).
ii MAJOR DNA BINDING PROTEIN
After the polymerase, the major DNA binding protein
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(mDBP) is the best characterised protein which has a role 
in DNA replication. The protein, which is encoded by gene 
UL29, has Mr of 128K and has been shown to be essential for 
virus replication (Conley et al., 1981; Weller et al., 
1983). Its precise role in virus replication has not yet 
been determined although it has been shown to denature 
poly-deoxyadeny1ic/poly-deoxythymidy1ic acid duplexes at 
4°C (Powell et al., 1981). mDBP mutants have been isolated 
which have altered sensitivities to inhibitors of virus DNA 
polymerase, suggesting a functional interaction between the 
two proteins (Chiou et al., 1985). It has been postulated 
that the mDBP may be active in the form of a complex with 
exonuclease as well as the DNA polymerase (Littler et al.,
1983) .
iii PS DNA BINDING PROTEIN
HSV-1 also encodes a double-stranded DNA binding 
protein (dsDBP), of Mr 65,000, which also co-purifies with 
the DNA polymerase and is regarded as being the homologue 
of the HSV-2 protein (Mr 55,000) described earlier (Vaughan 
et al., 1984). This protein is encoded by the gene UL42 
(Parris et al., 1988), which distinguishes it from Vaw65, a 
protein of similar Mr (Marsden et al., 1987). Although not 
required for DNA polymerase activity, dsDBP has a 
stimulatory effect on polymerase activity (Gallo et al., 
1989), supporting the suggestion that the in vivo 
polymerase holoenzyme is a heterodimer composed of 
polymerase and dsDBP subunits.
iv THE U L 5 , U L 8 , UL9 AND UL5 2 GENE PRODUCTS
There are four other genes which are known to be 
required for virus DNA replication; these are U L 5 , UL8, UL9
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and UL52. Until recently the products of these genes could 
not be identified among the proteins of infected cells.
They were only isolated when cloned into expression vectors 
(Olivo et al., 1988; 1989; Calder and Stow, in press). Due 
to the complex nature of DNA replication, these proteins 
could be responsible for a number of accessory functions, 
such as origin recognition, primer synthesis (and 
degradation) and topoisomerase. It is now known that the 
origin binding protein first described by Elias et al. 
(1986) is the product of the UL9 gene (Olivo et al., 1988; 
Weir and Stow, 1990).
Infection with HSV induces novel helicase and primase 
activities (Crute et al., 1988; 1989; Holmes et al., 1988), 
although the primase activity described by Holmes et al. 
(1988) was subsequently shown to be of cellular origin 
(Tsurumi and Lehman, 1990). However, the helicase activity 
described by Crute et al. (1988) has a tightly associated 
DNA primase activity (Crute et al., 1989). It is thought 
that these two activities are components of a three subunit 
enzyme composed of the products of the U L 5 , UL8 and UL52- 
genes, although the activities have not been assigned to 
individual genes. Recently, Calder and Stow (in press) have 
demonstrated that a combination of the products of genes 
UL5 and UL52 has helicase activity.
v ALKALINE EXONUCLEASE
An increased alkaline exonuclease activity associated 
with infected cells was first reported by Keir and Gold 
(1963). Further studies with the purified protein showed it 
to be composed of a single polypeptide chain and to exhibit 
not only 3 ’ and 5 ’ exonuclease activities but also 
endonuclease activity (Morrison and Keir, 1968; Hoffman and
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Cheng, 1978, 1979; Strobe1-Fidler and Francke, 1980; 
Hoffman, 1981). The importance of this enzyme in DNA 
replication is a matter for debate. Studies involving ts 
mutants have not fully resolved the significance of the 
exonuclease for virus DNA synthesis (Moss et al., 1979; 
Francke and Garrett, 1982; Moss, 1986); certainly, Wu et 
al. (1988) did not report it as being necessary for trans­
stimulation of DNA synthesis. It has been suggested that a 
possible role for the enzyme is in the packaging of progeny 
virus DNA (Weller et al., 1988).
1.10 PROTEINS INVOLVED IN NUCLEOTIDE METABOLISM 
i THYMIDINE KINASE
As well as the proteins already mentioned, which are or 
appear to be directly involved in DNA replication, there 
are other proteins which impinge on the replicative process 
indirectly. These are the enzymes of DNA metabolism. Among 
the most-well characterised of these is the thymidine 
kinase enzyme (TK) (Kit and Dubbs, 1963; Dubbs and kit, 
1964; Munyon et al., 1971), the product of gene UL23. In 
addition to thymidine, TK also phosphory1ates deoxycytidine 
and thymidylate (Jamieson and Subak-Sharpe, 1974; Jamieson
et al., 1974; Chen and Prusoff, 1978). However, 
deoxycytidine is not incorporated into the DNA, which 
indicates that the major route of dCDP (and therefore dCTP) 
synthesis is not the phosphorylation of dCMP, but is due to 
reduction of CDP (Jamieson and Subak-Sharpe, 1976). TK is 
not essential for virus growth in tissue culture, although 
the pathogenicity of these mutants is significantly reduced 
(Field and Wildy, 1978).
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ii RIBONUCLEOTIDE REDUCTASE
Another HSV-encoded enzyme involved in nucleotide 
synthesis is ribonucleotide reductase (RR) . RR catalyses 
the reduction of all four ribonuc1eoside diphosphates to 
their corresponding deoxyribonuc1eoside diphosphates 
(Cohen, 1972; Dutia, 1983). The enzyme is composed of two 
pairs of two subunits (ie at><2p 2 arrangement), which are 
encoded by two distinct but adjoining genes, (Preston et 
al., 1984; Bacchetti et al., 1984; Frame et al., 1985; 
McLauchlan and Clements, 1983), UL39 and UL40. The virus- 
encoded enzyme differs from its cellular homotype in that 
it is not sensitive to feedback inhibition by TTP (Cohen, 
1972). It has been postulated that, in contrast to TK, RR 
is an essential enzyme for virus growth in tissue culture. 
This is thought to be due to it occupying such a crucial 
role in the metabolic pathways concerned with supplying 
precursors for DNA metabolism (Preston, et al., 1974). 
However, it has subsequently been shown that under certain 
conditions, virus-infected cells can compensate for the 
loss of the large sub-unit of this enzyme, presumably by 
complementation of the activity by the host cell enzyme 
(Goldstein and Weller, 1988).
i i i DEOXYURIDINE-5»-NUCLEOTIDOHYDROLASE
HSV also encodes a deoxyuridine triphosphatase 
(dUTPase) (Wohlrab and Francke, 1980; Preston and Fisher,
1984), encoded by the gene UL50. Wohlrab and Francke,
(1980) showed this enzyme to catalyse the hydrolysis of 
deoxyribo-pyrimidine nucleoside triphosphates to 
monophosphates and pyrophosphate, with dUTP being by far 
the best substrate, followed by dCTP and dTTP. However, in 
a subsequent study Caradonna and Cheng (1981) showed that a
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partially-purified preparation of the enzyme was in fact 
specific for dUTP. Unlike its cellular counterpart, the 
virus-encoded enzyme activity is found in the nuclear 
fraction of infected cells and can be assayed at 4°C 
(Wohlrab and Franke, 1980; Caradonna and Cheng, 1981). The
cellular enzyme has two proposed functions. It has been 
suggested that in E. coli, the enzyme has an important role 
in the prevention of misincorporation of uracil into DNA 
(Shlomai and Kornberg, 1978), so a similar role for the 
HSV-encoded enzyme is possible. The enzyme has a very low 
Km for dUTP (<5 X 10-8 m) and it is thought that this is 
sufficient to keep the intracellular dUTP concentration far 
below the Km of the virus-encoded DNA polymerase (Wohlrab 
and Francke, 1980). The second proposed function of the 
enzyme is the supply of dUMP for de novo synthesis of dTMP, 
but Fisher and Preston (1986) considered this role to be 
secondary to the lowering of the concentration of the dUTP 
pool. The enzyme is dispensible for virus growth in tissue 
culture (Fisher and Preston, 1986).
iv URACIL-DNA GLYCOSYLASE
HSV also encodes its own uracil-DNA glycosylase. Work 
by Caradonna and Cheng (1981) showed that the activity of 
uracil-DNA glycosylase increased in cell extracts following 
infection with HSV. As this enzyme is the major topic 
discussed in this thesis, its role in the lytic cycle of 
the virus is discussed separately, in section 1.14.
1.11 EVOLUTIONARY COMPARISONS BETWEEN HERPESVIRUSES
It has already been stated that herpesviruses exhibit 
great diversity in their biological and morphological 
properties. This is reflected at the genomic level, and is
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exemplified by disparities in size, arrangement (both of 
which have already been discussed) and base composition. 
Base composition of herpesvirus DNAs has a wide variation, 
ranging from 75% G+C for B-virus down to 32% G+C for canine 
herpesvirus (Honess and Watson, 1977).
This diversity notwithstanding, it has long been 
postulated that there are evolutionary relationships 
between herpesviruses and this has led to comparisons being 
made. Until recently, these comparative analyses relied 
almost exclusively on techniques like DNA hybridisation 
(Davison and Wilkie, 1983) and on phenomena such as 
antigenic cross-reaction of proteins. However, these are 
only of use in studies within groups of closely related 
viruses. Before the advent of large scale sequencing 
protocols, there was no way of comparing relations between 
sub-families. Classification within the Herpesviridae in 
the past has been made according to general
characteristics, such as virion morphology and biology, and 
not by any direct evaluation of genome relatedness.
Although it is generally the case that realisation of DNA
sequence data has led to corroboration of the sub-group 
assignations originally made on the bases of morphology and 
pathogenesis in the herpesviruses, this is not always the 
case. For example, Buckmaster et al. (1988) investigated 
the assignation of Marek’s Disease Virus (MDV) and 
Herpesvirus of Turkeys (HVT) to the Gammaherpesvirinae. 
Using computer-aided comparisons of amino acid sequences 
deduced from DNA sequence data, they showed that both MDV 
and HVT are more closely related to VZV and HSV, members of 
the Alphaherpesvirinae, than to EBV which is a 
gammaherpesvirus. Not only that, but they also demonstrated 
a significant degree of colinearity in the genome
organisation between both of the avian viruses and VZV (and
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HSV) .
Direct comparisons of DNA sequences often provide 
little information about homology, and so the method of 
choice for performing such analyses has been computer aided 
comparison of the predicted amino acid sequences. This has 
facilitated the study of the relationships between the 
herpesviruses. The relationships between HSV-1 and other 
human herpesviruses are discussed below.
1.11.1 HSV-1 AND OTHER ALPHAHERPESVIRUSES
i HSV-2
HSV-1 and HSV-2 are two very closely related members of 
the Alphaherpesvirinae. They share multiple antigens and 
will cross-neutra1ise (Honess et al., 1974). The existence 
of a close relationship between the two serotypes was 
confirmed by the isolation of intertypic recombinants 
(Timbury and Subak-Sharpe, 1973; Davison and Wilkie,
1983b). There is extensive DNA sequence homology between 
the genomes of these viruses (Kieff et al., 1972), and 
Southern blotting analysis demonstrated that this homology 
is present, at varying levels, throughout the length of the 
genomes, confirming that the genomes are col inear (Davison 
and Wilkie, 1983a).
ii VZV
HSV-1 also exhibits DNA sequence homology to VZV 
(Davison and Wilkie, 1983a). As a technical qualification, 
the L segment of the genome of VZV is inverted with 
respective to the prototypic arrangement of the HSV genome 
(Davison and Wilkie, 1983b). The first regions of the
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genomes to be compared were the S segments (McGeoch, 1984; 
Davison and McGeoch, 1986). The HSV-1 Us region contains 
ten complete genes (US2-US11) and the major parts of two 
more (US1 and US12), with each copy of Rs containing one 
gene (IE175). The VZV Us region contains two complete genes 
(US2 and US3) and the major parts of two more (US1 and 
US4), with each copy of Rs containing three complete genes 
(RSI, RS2 and RS3). These studies demonstrated that each 
gene present in VZV has a homologue in HSV-1, but that six 
of the HSV-1 genes have no counterparts in VZV. The two 
viruses have a different layout of genes in the S segment, 
and this has been interpreted as a result of large scale 
expansions and contractions of the unique and repeat 
regions, brought about by recombinational events in the 
evolution of the viruses.
With the publication of the sequence of HSV-1 Ul 
(McGeoch et al., 1988), comparisons can be made between the
two viruses for this region. The VZV L region is predicted 
to contain 60 genes (Davison and Scott, 1986) and HSV-1 is 
reckoned to have 57 different genes in the L segment 
(although there are two copies of IE110). On the basis of 
DNA sequence interpretation, there are five genes in the L 
region of VZV without counterparts in HSV-1 and two HSV-1 
genes without homologues in VZV. In general, these 
comparisons have shown that, although the genomes differ 
widely in terms of base composition, they are closely 
comparable in the arrangement of their genes, especially in
U L -
1.11.2 HSV-1 AND BETAHERPESVIRUSES AND GAMMAHERPESVIRUSES
DNA sequence data have been published for some of these 
viruses and varying levels of similarity have been
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observed. HCMV (a betaherpesvirus) and EBV (a 
gammaherpesvirus) show essentially no homology to HSV at 
the DNA sequence level, as examined by DNA cross­
hybridisation studies (Honess and Watson, 1977). Studies by 
Davison and Taylor (1977) compared amino acid sequences 
between VZV and EBV and found twenty nine pairs of genes 
which exhibited amino acid sequence homology, ranging from 
strongly conserved to weakly conserved examples. A further 
fourteen pairs were also designated as being probably 
homologous, on the basis of such properties as the 
distribution of hydrophobic amino acids. All of these 
related genes are present in U l » with both viruses 
possessing genes not found in the other. No homologous 
pairs were detected in the short segments of the genomes. 
Sequence data for HCMV (Chee et al., 1990), indicate that a 
similar relationship exists between it and the alpha- 
herpesviruses (and with EBV).
These comparisons provide evidence that all the human 
herpesviruses may be descended from a common ancestor. 
However, evolution has led to extensive variation and 
consequently the genomes of these viruses are widely 
diverged. This is reflected in the phenotypic variety 
exhibited by these viruses today.
1.12 HSV MUTAGENESIS
The last section of this introduction starts with an 
account of some of the functional analyses which have been 
performed on HSV by mutagenesis. This not only leads into 
the major technique used in the work described later, but 
also introduces the formation of uracil as a mutagenic 
event and the role of uracil—DNA glycosylase in its 
removal. This is central to the experiments described in
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the remainder of this thesis.
The biology of herpes viruses is very diverse and has
been subject to a wide variety of studies. Perhaps the most
fundamental objective in the field of virus molecular
biology is the elucidation of the functions encoded in the
genome. One tool which has been especially useful in this
field has been that of mutagenesis. The many different
techniques involved in these kinds of analyses have given
rise to a wide variety of mutation classes, including
Brown et al., 1973 and
syncytial plaque morphology (syn, for example see/VLittle
and Schaffer, 1981), temperature-sensitivity (ts, Preston
et al., 1988), insertion (Goldstein and Weller, 1988),
virion host shut-off (vhs, Kwong et al.t 1988) and deletion
(Smith et al., 1989). Many of these mutations are
spontaneous, or at least have been fortuitously isolated,
with the other lesions being deliberately engineered.
1.12.1 ENGINEERED MUTATIONS
One of the major diagnostic aids in the analysis of 
those genes whose functional potential is obscure, is 
disruption of the protein coding sequence. The resulting 
mutants can then be subjected to phenotypic analysis. There 
are many published examples of this and some have been 
referred to above. The usual methods for achieving such 
disruption are deletion of all or part of the reading 
frame, or insertion of a segment of foreign DNA into the 
gene under investigation. These manipulations are usually 
performed on plasmid-cloned copies of the genes. The 
mutated plasmid-borne alleles are then transferred into the 
genome of the parent virus by homologous recombination of 
flanking sequences.
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One of the major drawbacks of deletion or insertion 
mutagenesis is difficulty in recognising the recombinant 
progeny. If the function of the gene which has been mutated 
is not known then the phenotype of the progeny cannot be 
predicted. Homologous recombination works, but the 
efficiency is limited. In the work described in this 
thesis, the recombination efficiency is lower than observed 
elsewhere, perhaps because of the use of a large (4.1 kbp) 
insert. Even with smaller inserts it may be necessary to 
screen thousands of plaques in order to be confident of 
isolating a mutant. If the gene under investigation was 
required for growth in tissue culture then the likelihood 
of isolating a mutant would be reduced to zero. Also, 
recombinant viruses may be restricted in their growth 
properties and number of progeny, and so may be overgrown 
by the wt parent. There have been several attempts to 
circumvent this problem, most relying on the use of a 
selectable marker. Under selection pressure only those 
recombinants carrying this selectable marker are encouraged 
to grow and can be isolated by plaque-purification. One 
method involves using the HSV thymidine kinase (TK) gene 
(Post and Roizman, 1981). The HSV TK gene product is non- 
essential for virus growth in tissue culture and it has 
been possible to isolate mutant strains of HSV which are 
deficient in TK activity (Dubbs and Kit, 1964). In 
addition, there are cell/medium selections both for and 
against expression of the TK gene (Post and Roizman, 1981). 
Early mutagenesis experiments involved insertion of foreign 
DNA sequences into the TK locus in the HSV genome. The 
progeny would have a tk- phenotype against a tk+ 
background. This technique potentially allows for rapid 
selection of the progeny, but the site of mutagenesis is 
restricted to within the TK gene. This was overcome by a 
modification of the procedure. In the first stage, the HSV-
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1 TK gene is inserted into a plasmid-borne copy of the 
target region of the genome. This construct is then 
inserted into the genome of a tk- virus at the required 
locus by homologous recombination of the flanking 
sequences. Recombinant progeny, which are tk+ , can be 
screened for, against the parental virus which have a 
tk~ phenotype. Once purified and confirmed, these insertion 
mutants can then be used to generate deletion mutants. The 
procedure for this is similar to the previous one.
Deletions are engineered into plasmid-cloned copies of the 
gene. These are again recombined into the mutant virus. The 
recombination event this time removes the TK gene (and thus 
the tk+ phenotype) as well as the target sequences which 
flank it. In this case progeny are screened for their tk~ 
phenotype against a background of tk+ parents.
In practice this technique apparently works well. There 
are however difficulties which make the construction and 
screening of these mutants complicated and technically 
demanding. Special tk- cell lines are required for 
selection and maintenance of these viruses. The isolation 
of the engineered viruses demands the use of different 
tissue culture media and these may not be optimal for 
growth of both the viruses and the cells which they infect. 
It is also the case that the mutation is not engineered 
into a wt virus but a mutant which is tk~ and this may have 
ramifications for the genotype and/or phenotype of the 
progeny. Although the TK enzyme is not required for.growth 
in tissue culture, little is known about how the enzyme 
interacts with other aspects of nucleotide metabolism and 
how mutations in other genes relate to the growth of tk- 
viruses in culture.
Recently, mutagenesis techniques which are without the
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drawbacks described so far have been sought. One method 
along these lines was the introduction of the E. coli LacZ 
gene (for example, see Hall et al., 1983). This gene can be 
used as a phenotypic marker, visualised by the simple 
addition of 5-bromo-4-ch1oro-3-indo1y 1 JB-D- 
ga1 actopyranoside (X-gal), a chromogenic substrate for p- 
ga1actosidase, the product of the LacZ gene. Once again, 
the mutation, in this case an insertion, is constructed in 
plasmid-cloned copies of the target gene which is then co­
transfected into wt virus as a selectable marker. The 
detection of recombinant progeny virus is facilitated by 
addition of X-gal to the agar used to overlay the tissue 
culture plates. One limitation of this system is the 
efficiency of expression of the marker gene. In practice, 
this can be overcome by fusing the gene to a promiscuous 
promoter, eg the SV40 early promoter, as in the plasmid 
pFJ3 (see fig. 2.2). Recombinant viruses containing the 
LacZ gene, express it to a detectable level (work in this 
thesis). This has the advantage of using wt parent virus 
and dispenses with the need for tk~ cell lines. This 
technique has been used in the generation of the mutant 
viruses discussed in this thesis.
1.12.2 SPONTANEOUS MUTATIONS
Amongst the challenges which the cell has to meet, one 
of the most important is the prevention of an unacceptably 
high mutation rate. Sophisticated mechanisms have evolved 
to ensure that DNA is replicated with high fidelity, and 
mismatch repair activities exist which remove 
misincorporated residues which have escaped proofreading 
during replication. Potentially mutagenic changes can also 
occur in nonreplicating DNA, both by exposure to mutagenic 
agents and under normal physiological conditions (Lindahl,
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1982).
1.13 URACIL IN DNA
Spontaneous degeneration of DNA due to depurination and 
depyrimidination of DNA is a normal occurrence in mammalian 
cells (Lindahl, 1982). One type of spurious residue which 
has been found in DNA is uracil. The two pathways which 
result in the presence of uracil in DNA are:
1) Misincorporation of dUTP (as dUMP) into the DNA
during replication (Bessman et al., 1958).
and
2) In situ deamination of cytosine residues in the DNA
(Shapiro et al., 1973).
These are discussed in turn below.
1.13.1 MISINCORPORATION OF dUTP
As has already been stated, it is a physiological 
possibility that, during normal DNA replication, dUTP (as 
dUMP) could be incorporated instead of dTTP into the newly 
synthesised DNA (Tye et al., 1977). This misincorporation 
is minimised, but perhaps not totally suppressed, by 
selective enzymatic degradation of dUTP in cells by the 
enzyme dUTPase (Bertani et al., 1963). It has been 
demonstrated that HSV-1 encodes its own dUTPase (Preston 
and Fisher, 1984).
1.13.2. IN SITU DEAMINATION OF CYTOSINE
In vivo, cytosine is the most labile of the four DNA 
bases to heat-induced hydrolysis (Shapiro and Klein, 1966)
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and direct measurements of the rate of deamination of 
cytosine to uracil in DNA have indicated that this process 
occurs at a significant rate under physiological conditions 
(Lindahl and Nyberg, 1974). Cytosine deamination can occur 
spontaneously (Hyatsu, 1977) and it is estimated that there 
is premutagenic deamination of approximately one hundred 
cytosine residues per genome per day in a typical mammalian 
cell (Lindahl, 1982). Apart from its spontaneous 
occurrence, deamination can also be mediated by exposure to 
sodium bisulphite or to nitrous acid (Shapiro and Klein, 
1966). Such lesions would, unless corrected, give rise to a 
G.C to A.T transition mutation upon subsequent rounds of 
replication (Lindahl, 1982).
1.14 THE HSV-ENCODED URACIL-DNA GLYCOSYLASE AND ITS ROLE IN 
REMOVING URACIL FROM DNA
Enzymatic cleavage of DNA occurs by hydrolysis of 
phosphodiester bonds by deoxyribonucleases. Lindahl (1974, 
1976) described a group of DNA-cleaving enzymes which 
hydrolyse glycosidic base-sugar bonds as opposed to 
phosphodiester bonds and which are active in DNA repair. 
These are the DNA glycosylases (Lindahl, 1974). Although 
several of these have been isolated, for example 
hypoxanthine-DNA glycosylase, 3-methyladenine-DNA 
glycosylase I and IT, the best studied is uracil-DNA 
glycosylase (Lindahl, 1976), which is also the most 
abundant (Varshney et al., 1988). This enzyme has been 
isolated from a variety of sources, from bacteria (Cone et 
al., 1974) to humans (Caradonna & Cheng, 1980). It acts on 
DNA which contains dUMP in single-stranded regions or base- 
paired to either dAMP or dGMP in double—stranded DNA, 
releasing free uracil and DNA of unaltered chain length 
containing apyrimidinic sites. Lindahl et al. (1977)
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demonstrated that the mechanism of action of the enzyme was 
not by dephosphorylation or by a trans-N-deoxyribosy1ase 
type reaction but by a direct cleavage of the glycosidic 
base-sugar bond. The enzyme shows no activity on free dUMP, 
RNA or the four common deoxyribonuc1eotides in DNA (Lindahl 
et al., 1977; Friedberg et al., 1975). The enzyme, as 
isolated and purified from E. coli, has a Km for uracil of 
approximately 4 X 10-8 and a turnover number of 800 uracil 
residues released per min (Lindahl et al., 1977).
As was stated earlier, Caradonna and Cheng (1981) 
reported induction of a uracil-DNA glycosylase activity in 
cells infected with HSV-1 and HSV-2, and recently Caradonna 
et al. (1987) described the isolation of an HSV-2 cDNA 
which encoded uracil-DNA glycosylase activity. This was 
achieved by construction of a cDNA library with mRNA from 
HSV-2-infected cells. Pooled isolates from this library 
were used in hybrid-arrest and in vitro translation 
experiments to isolate a clone which apparently encoded 
uracil-DNA glycosylase activity. Subsequent analysis, by 
Southern blotting, mapped this cDNA to between 0.065 and 
0.080 map units (mu) on the prototypic HSV genome.
It has already been stated that there are two principal 
pathways which could result in the presence of uracil in 
the DNA, namely misincorporation of dUTP during replication 
and in situ deamination of cytosine to uracil. It is 
possible that uracil-DNA glycosylase could have a role in 
the correction of either (or both) event(s). However, it 
has been suggested that minimising the misincorporation of 
uracil (from dUTP) into DNA during replication is not the 
role of uracil-DNA glycosylase, due to the presence of the 
dUTPase. The latter enzyme lowers the intracellular pool of 
dUTP, making misincorporation a dynamically unfavourable
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reaction (Preston and Fisher, 1984). The ramifications of 
misincorporation of dUTP are not as serious as those of 
deamination of cytosine as the former case does not result 
in a mutation. For these reasons, it is now generally 
accepted that the in vivo role of the uracil-DNA 
glycosylase enzyme is to initiate the repair of G.U base 
pairs, which have a mutating potential (Caradonna et al., 
1987; Caradonna and Cheng, 1980). The enzyme itself is 
involved at the earliest stage of this procedure. It 
recognises the presence of uracil in the DNA and it removes 
it by hydrolysis of the glycosidic base-sugar linkage. 
Removal of the uracil creates an apyrimidinic site in the 
DNA. Indeed, the collective action of DNA glycosylases is 
the major cause of the formation of apurinic or 
apyrimidinic (AP) sites in DNA (Lindahl, 1979). Although 
these lesions are repaired very efficiently in vivo, they 
occur with sufficient frequency to be considered as being 
occasionally responsible for inactivation or mutagenesis of 
cells (Kunkel et al., 1981). However, it seems unlikely 
that the generation of such AP sites in the DNA plays a 
major role in spontaneous mutagenesis on its own. This 
conclusion is drawn because of the existence of E. coli xth 
mutants. These are deficient in the major AP endonuclease 
and presumably have a reduced ability to remove these 
sites. It has been demonstrated that these mutants do not 
exhibit an increased spontaneous mutation frequency (Weiss 
et al. , 1978; Rogers and Weiss , 1980) .
MATERIALS AND METHODS
40
2.1 ENZYMES
Restriction endonucleases, T4 DNA polymerase and T4 DNA 
ligase were obtained from Bethesda Research Laboratories. 
The large fragment of Escherichia coli DNA polymerase I 
(Klenow) was obtained from Boehringer Corporation pic, as 
was calf intestinal phosphatase.
Lysozyme was purchased from Sigma Chemical Company Ltd.
2.2 CHEMICALS
5-bromo-4-chloro-3-indoly1 /3-D-ga1actopyranoside (X- 
gal) was obtained from Sigma Chemical Company Ltd.
Other laboratory chemicals were routinely purchased 
from BDH or Sigma and were generally of analytical grade or 
better.
Unless stated otherwise, all tissue culture growth 
media and supplements were purchased from Gibco-BRL pic.
2.3 RADIOCHEMICALS
All radiochemicals were obtained from the Radiochemical 
centre, Amersham.
2.4 BUFFERS AND SOLUTIONS
Boiling mix 30% (v/v) Stacking gel buffer
6% (v/v) SDS
30% (v/v) Glycerol
15% ^3-Mercaptoethanol
1% Bromophenol blue
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Destain (for protein gels)
5% Methanol
7% Acetic acid
in deionised H 2 O
E buffer 20 mM Tris base
10 mM NaH2 PO4 .2H2 0
0.5 mM EDTA
Fix (for protein gels)
47% Methanol
47% Deionised H20
6% Glacial acetic acid
HEBS buffer 140 mM NaCl
p H 7 .05 5 mM KC1
0.5 mM Na 2HPO4
5 mM D-glucose
20 mM Hepes
NTE 10 mM Tris-HCl
100 mM NaCl, pH 7.4
1 mM EDTA
PBS A 170 mM NaCl
3.4 mM KC1
1 mM Na2 HP 04
2 mM KH 2 P04
pH 7.2
Complete PBS PBS A
6 . 8 mM CaCl2
4.9 mM MgC12
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Protein extract dialysis buffer
50 mM Tris-HCl, pH 7.5
1 mM Dithiothreitol
1 mM MgC12 
20% (v/v) Glycerol
Protein 200 mM K-phosphate, pH 8.0
extraction 1 mM EDTA
buffer 2 mM MgCl2
2 mM Dithiothreitol
1% (v/v) Triton X-100
1 mM PMSF
20% (v/v) Glycerol
RNase mix
100 ul RNase A soln. (10 mg/ml)
50 ul RNase T1 (0.67% v/v)
850 ul H 20
The solution was prepared fresh each 
time and boiled for 10 min before use.
RSB 10 mM Tris-HCl
10 mM K C 1 , pH 7.4
1.5 mM MgC12
Stain (for protein gels)
Fix + 0.2% Coomassie Brilliant Blue 
R-250
STET 8% (w/v) Sucrose
0.5% (v/v)Triton X-100 
50 mM EDTA, pH 8 .0
50 mM Tris-HCl, pH 8.0
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TBE 90 mM Tris-base
90 mM Boric acid
2.5 mM EDTA, pH 8.3
TE 10 mM Tris-HCl, pH 8 .0
0.1 mM EDTA, pH 8 .0
Triton lysis Solution
2% . Triton X-100
50 mM Tris-HCl pH 8 .0
6.25 mM EDTA
in deionised H 2 O
Zweig’s buffer 100 mM Tris-HCl, pH 8.0
10% Glycerol
0.5% Nonidet P-40
0.5% Na deoxycholate
0.2 mM PMSF
2.5 BACTERIAL GROWTH MEDIA
2YT 85 mM NaCl
1.0% (w/v)Bactopeptone 
1 .0% (w/v)Yeast extract.
L-Broth 177 mM NaCl
1.0% (w/v)Bactopeptone.
SOC 2.0% (w/v)Bactotryptone
0.5% (w/v)Yeast extract 
10 mM NaCl
2.5 mM KC1
10 mM MgC12
10 mM MgSO*
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20 mM D-Glucose
L-Broth Agar 1.5% (w/v) agar in L-Broth.
Antibiotics L-Broth Agar supplemented with
either
50 ug/ml ampicillin (Penbritin) or 
20 ug/ml tetracycline.
2.6 TISSUE CULTURE GROWTH MEDIA
ETCio 300 ml Sterile distilled H 2 O
36 ml Glasgow Modified Eagle’s
Medium (GMEM) (Busby et 
al., 1964)
14 ml NaHC03
100 U/ml Penicillin
100 ug/ml Streptomycin
7.8 ml L-Glutamine
40 ml Calf serum
20 ml Tryptose phosphate broth
EMC5
GMEM supplemented with
100 U/ml penicillin 
1 0 0 ug/ml streptomycin 
1.5% methyl cellulose
5% calf serum
Agar Overlay (for screening recombinant virus) 
GMEM supplemented with
0.64% Noble Agar
1.5 mM X-gal
1% Calf serum
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PIC Phosphate-free Eagle’s medium
supplemented with 1% newborn calf 
serum.
2.7 TISSUE CULTURE AND VIRUS STOCKS
Throughout this study baby hamster kidney clone 13 (BHK 
C13) cells were used (MacPherson and Stoker, 1962). These 
were incubated in 35 mm, 50 mm or 90 mm tissue culture 
plates as required or in 80 oz roller bottles, under ETCio 
unless stated otherwise. Tissue culture plates were 
incubated at 37°C in a humidified atmosphere of air 
enriched with 5% CO2 and roller bottles were gassed to 5% 
CO2 , capped and kept rotating at 37<>C.
Throughout this study wild-type HSV-1 strain 17+ (Brown 
et al., 1973) was used. Two mutants derived from HSV-1 17+ 
which were also used, were a dUTPase deficient mutant - 
dut-1218 (a gift from Dr V G Preston), and a 
phosphonoacetic acid (PAA) resistant mutant - PAAr-1 (a 
gift from M Murphy), dut-1218 contains an 8 -mer Hindlll 
oligonucleotide linker inserted into the Kpnl site within 
the coding site of the dUTPase gene, UL50 (Fisher and 
Preston, 1986). PAAr-1 (Hay and Subak-Sharpe, 1976)
contains a mutation within the DNA polymerase gene UL30 
(Crumpacker et al., 1980).
BHK C13 cells were grown until 90% confluent under 
ETC 1 0 • They were infected at the required multiplicity of 
infection (moi) as follows. The medium was aspirated from 
the cells and was replaced with the appropriate virus in 
ETCio- The cells were returned to the incubator for 1 hr 
before the inoculum was removed, the cells were washed 
twice with ETC10 and overlaid with the appropriate medium.
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Elite virus stocks (with low serial passage number) 
were used to infect BHK C13 monolayers (approximately 80% 
confluent) at a multiplicity of 1 pfu/300 cells in 40 ml of 
ETCio* The infected cells were incubated at 31oC and 
harvested when the cpe was maximal (usually 4-6 days pi).
The infected cells were shaken into the medium and 
pelleted by centrifugation at 2,000 rpm for 10 min. The 
supernatant was decanted and centrifuged at 1 2 , 0 0 0  rpm for 
2 h. The pellet was resuspended in 5 ml supernatant and 
disrupted u 1trasonica1ly in a bath sonicator (50 W at 4oC) 
until homogeneous. This was retained as the supernatant 
virus stock. The pellet from the first centrifugation was 
resuspended in 5 ml of supernatant and disrupted 
ultrasonically as before, freeze/thawed, re-sonicated and 
centrifuged at 2,000 rpm for 10 min. The supernatant was 
retained and the pellet was resuspended in 5 ml of ETCio 
and treated as for the pellet from the first 
centrifugation. The two supernatants were pooled and 
retained as the cell-associated virus stock.
Virus stocks were stored at -70<>C and were checked for 
sterility and titrated before use.
2.8 STERILITY CHECKS
Brain heart infusion (BHI) plates were prepared by 
dissolving 26 g of Difco Bacto BHI agar in 500 ml of 
deionised H 2 O and autoclaving for 20 min. This was cooled 
to around 40°C and poured onto 50 mm petri dishes (BHI 
plates). Alternatively, 50 ml of horse blood (Biocult) was 
added immediately prior to pouring (BHI blood agar plates).
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Virus stocks were tested for fungal contamination by 
streaking, in duplicate, onto BHI plates. The plates were 
sealed with Parafilm and incubated at room temperature for 
7 days. Yeast or bacterial contamination was detected by 
streaking onto BHI blood agar plates, which were incubated 
at 37°C for 7 days. If after this time no contamination was 
detected the stocks were considered to be sterile.
2.9 TITRATION OF VIRUS STOCKS
Virus samples, whether from co-transfection or 
otherwise, were titrated at 31°C and/or 37oC onto confluent 
monolayers of BHK C13 cells on 50 mm plates as follows. 
Serial tenfold dilutions of virus were prepared by taking 
0.1 ml of virus into 0.9 ml complete PBS supplemented with 
5% calf serum. 0.1 ml of this dilution was taken into 
another 0.9 ml of PBS with calf serum, and so on. Generally 
speaking, the dilutions from 1 0- 2 to 1 0 -6 were used for 
titration. The plates were taken from the incubator, the 
medium was removed and 0 . 2 ml of virus from the respective 
dilution was added to the plates. The plates were returned 
to the incubator for 1 hr before the inoculum was removed 
and the plates overlaid with EMC5. The plates were 
inspected daily. After 2 days the plates were stained with 
Giemsa stain for 30 min at room temperature and the plaques 
counted under a dissection microscope.
2.10 PREPARATION OF VIRUS DNA
Confluent monolayers of BHK C13 cells in 80 oz roller 
bottles were infected at a moi of 1/300 pfu/cell and 
incubated until the cpe was extensive. The virus-infected 
cells were harvested by shaking into the medium. This was 
then centrifuged at 2,000 rpm for 10 min. The supernatant
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was retained (SN1) and the pellet was resuspended in 10 ml 
of RSB. Nonidet P-40 (NP40) was added to a final 
concentration of 0.5% (v/v) and was left on ice for 10 min. 
The mixture was centrifuged as before to pellet the nuclei. 
The supernatant (SP2) was added to SP1 and the pellet 
re-extracted with RSB/NP40 as before. After the 
centrifugation step the supernatant was added to SN1 and 
SN2. This was centrifuged at 12,000 rpm for 2 h at 4oC in a 
Ti50 rotor. The supernatant was discarded and the pellet 
resuspended in 8 ml of NTE by sonication. To this was added 
EDTA and SDS to a final concentration of 10 mM and 2% (w/v) 
respectively. This was mixed gently with an equal volume of 
buffer saturated phenol. The phases were left to separate 
for 5 min at room temperature followed by 5 min on ice. The 
aqueous phase was re-extracted twice more with buffer 
saturated phenol on a rotary mixer, followed by an 
extraction with chloroform:iso-amyl alcohol (24:1). The 
aqueous phase was decanted and to this was added 0 . 1  
volumes of 3 M NaOAc and 2.5 volumes of ethanol. The DNA 
was recovered and resuspended in T E .
2.11 CO-TRANSFECTION OF VIRUS DNA WITH PLASMID DNA
Co-transfection of virus DNA with plasmid DNA was 
performed by the calcium phosphate technique followed by a 
dimethyl sulphoxide (DMSO) boost (Stow and Wilkie, 1976). 
BHK C13 cells were grown to 90% confluence under ETCio* The 
medium was aspirated and replaced with the transfection 
mixture, which was composed of the following,* 1 ml Hebs pH 
7.05, 70 ul of 2M CaCJ.2 > 5 ul of calf thymus DNA (1
mg/ml), 200 pfu of virus DNA and plasmid DNA. The plasmid 
DNA was prepared by digesting 60 ug of plasmid DNA with 100 
units of restriction enzyme. The number of cutting sites 
appeared not to be significant as long as the plasmid had
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approximately 1 kbp of sequence homologous to the virus DNA 
on either side of the lesion. The digestion fragments were 
separated by electrophoresis on a 1% agarose gel. The 
fragment of interest was excised from the gel with a 
scalpel and the DNA recovered by electroelution. This 
fragment was purified by "Geneclean" (BI0101, USA), a 
DNA-binding matrix based on powdered glass, used according 
to the suppliers’ instructions. The co-transfections were 
1 performed in duplicate, adding 0.1, 0.5, 1 and 5 ug of
purified fragment to different plates. The plates were 
returned to the incubator for 1 h. After this time, 4ml of 
ETCio was added to each plate and the incubation was 
continued.
At 4 h pi the plates were removed from the incubator. 
The medium was aspirated and the plates washed twice with 
ETCio without serum before addition of 1 ml of DMSO (25% in 
Hebs, pH 7.05). This was left on for 4 mins before being 
removed. The plates were then washed twice more with ETCio 
without serum before being overlaid with 4 ml of ETCio- The 
plates were returned to the incubator and checked daily for 
cpe. After extensive (>75%) cpe was observed, the virus was 
harvested into the medium by scraping with a rubber 
policeman. This was disrupted ultrasonically and titrated 
as described in section 2.9.
2.12 DETECTION AND PURIFICATION OF RECOMBINANT VIRUS 
PROGENY
Recombinant viruses (containing the E. coli LacZ gene) 
were co-transfected as described in section 2 . 1 1 and 
titrated as described in section 2.9 except that instead of 
overlaying with EMC5, the plates were overlaid with agar 
overlay containing X-gal, a chromogenic substrate for B- 
ga1actosidase. These plates were again returned to the
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incubator and left overnight. After this time, plaques 
formed by recombinant progeny virus expressing the p- 
galactosidase gene turned blue. The recombinant viruses 
were purified to homogeneity by four successive rounds of 
plaque purification, picking ten blue plaques at each round 
and passing these. An elite stock, made from a single, 
isolated blue plaque picked at the fourth round of 
purification was used in all subsequent experiments 
involving the virus in question.
2.13 RESTRICTION ANALYSIS OF MUTANT VIRUSES
The genotype of the mutants was confirmed by 
restriction analysis, essentially by the method of Lonsdale
(1979). BHK C13 cells were seeded in 24 well tissue culture 
plates and after 12 hours the medium was removed and 
replaced by 0.45 ml of PIC. After a further 12 hours the 
cells were infected with virus at a moi of 10 pfu/cell and 
maintained again in PIC. At 2 h pi, 50 uCi of 32p in 50 ul 
of PIC was added to each well. The plates were returned to 
the incubator. Once the cpe was extensive (usually 2-3 
days), the cells were lysed by addition of 0.5 ml of 5%
SDS. The cells were scraped off the plate with a 
micropipette tip and transferred to a sterile 10 ml conical 
tube. The lysate was extracted with an equal volume of 
buffer-saturated phenol, incubated at room temperature for 
5 min and then on ice for 5 min. The aqueous phase was 
ransferred into a clean assay tube and the DNA was
precipitated by addition of 2 volumes of ethanol and 
pelleted by centrifugation at 2,000 rpm for 10 mins at 4°C. 
The pellet was drained, dried and resuspended in 175 ul of 
sterile distilled H 2 O and 25 ul RNase mix by gentle 
agitation at 37oC. The solution was stored at -20°C until 
use.
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Samples (20ul) of virus DNA were digested with between 
1 and 2 units of appropriate restriction enzymes according 
to the suppliers instructions. After A hours the DNA 
restriction fragments in the samples were separated by 
horizontal agarose electrophoresis overnight’ at AOV, with 
the agarose concentration being decided by the size of the 
restriction fragments generated by the digest. After 
electrophoresis, the gel was dried and subjected to 
autoradiography at -70°C.
2.1A ONE-STEP GROWTH CURVE
Confluent monolayers of BHK C13 cells on 35 mm 
plates were infected with virus at a moi of 5 pfu/cell and 
incubated for 1 h. After this time, the plates were washed 
twice with ETCio without serum and overlaid with 1.5 ml of 
ETCio* Plates were harvested at 1 , 2 , 3, A, 6 , 8 , 1 0 , 1 2 ,
21 and 25 h pi by scraping into the medium with a rubber 
policeman. The harvests were disrupted u 1trasonica1ly and 
titrated onto 50 mm plates of confluent BHK C13 cells as 
previously described.
2.15 PREPARATION OF "EARLY" EXTRACTS
To prepare extracts of proteins produced in the absence 
of DNA synthesis, monolayers of BHK C13 cells (80% 
confluent) were used. The medium was removed and replaced 
by ETCio supplemented with PAA at 0.3 mg/ml. The cells were 
incubated for 1 h before being infected with virus at a moi 
of 20 pfu/cell. The virus was allowed to absorb for 1 h at 
37oC before being removed and the cells overlaid with
ETCio supplemented with 0.3mg/ml PAA. At 10 h pi extracts 
were prepared from the cells as described in section 2.16.
52
2.16 PREPARATION OF INFECTED AND MOCK-INFECTED CELL 
EXTRACTS FOR ENZYME ASSAYS
Extracts from HSV-infected or mock-infected monolayers 
of BHK C13 cells were prepared as described by Caradonna 
and Cheng (1980). At the appropriate time-point, the medium 
was removed from the plates, which were then rinsed twice 
with PBS. The cells were then scraped into PBS and pelleted 
by centrifugation at 2,000 rpm for 10 min at 4°C. The 
pellet was resuspended in 5 volumes of protein extraction 
buffer and subjected to 4 cycles of freeze/thawing in dry- 
ice/ethanol. The suspension was then disrupted 
u 1trasonica1ly before standing on ice for 1 h. Following 
this, the suspension was centrifuged at 2 , 0 0 0  rpm for 10 
min to pellet cell debris. The supernatant was dialysed 
against 1 0 0 volumes of protein extract dialysis buffer at 
4-oC overnight. The dialysate was centrifuged at 2,000 rpm 
for 10 min to pellet precipitated material and the 
supernatant removed and stored at -70°C until use.
2.17 GLYCEROL STOCKS OF BACTERIA
Bacterial stocks were prepared from 20 ml overnight 
shaking cultures at 37°C in L-Broth or 2YT. These were 
centrifuged at 5,000 rpm for 10 min at 4°C. The pellets 
were resuspended in 4 ml of 2% (w/v) bactopeptone before 
addition of 4 ml 80% (v/v) glycerol. The stocks were 
routinely stored at -70oC
2.18 HSV-1 RECOMBINANT PLASMIDS
Recombinant plasmids were grown in E. coli strains DH5 
and DH5£(, obtained from Bethesda Research Ltd. The 
following recombinant plasmids were used in this work.
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pGX23, containing the HSV-1 BairiHI e fragment, was provided 
by Dr V G Preston. Another plasmid used extensively 
throughout this work was pFJ3, provided by Drs F J Rixon 
and J McLauchlan. The structures of these plasmids are 
shown in figures 2 . 1 and 2 .2 , respectively.
2.19 TRANSFORMATION OF BACTERIAL CELLS WITH PLASMID DNA
Host bacterial strains, either DH5 or DH56C were 
obtained from Bethesda Research Ltd and used according to 
the suppliers instructions. 2 0 ul of competent ba.cteria was 
transferred to a 1.5 ml Eppendorf tube on ice. 100-500 ng 
of plasmid DNA was added and the mixture was incubated on 
ice for 20 min. The bacteria were heat-shocked at 42oC for 
40 s before being returned to ice. 80 u-1 of SOC medium was 
added to the bacteria which were then incubated at 37°C for 
1 h in an orbital incubator. 50 ul aliquots of the 
bacterial suspension were then plated out onto L-broth agar 
plates containing selective antibiotics. Colonies were 
picked and restreaked in parallel onto L-broth agar plates 
containing an antibiotic which the plasmid would confer 
resistance to and one which the plasmid would not. i.e. 
bacteria transformed with the plasmid pGX23 would be 
ampicillin resistant and tetracycline sensitive. Colonies 
exhibiting the correct spectrum of antibiotic resistance 
and sensitivity were picked and small scale cultures were 
prepared as described in section 2 .2 0 .
2.20 SMALL SCALE PLASMID DNA PREPARATION
Colonies exhibiting the desired antibiotic spectrum 
were picked with sterile toothpicks into sterile universals 
containing 2 ml of L-broth containing the appropriate 
antibiotic and incubated overnight at 37oC in an orbital
Figure 2.1 : The plasmid pGX23
The structure of plasmid pGX23 is depicted in this 
figure. pAT153 sequences extend from position 1 to 3657, 
and the HSV-1 BanMI e fragment (residue 2907 to 11820 in 
the virus genome, McGeoch et al.f 1989) is from position 
3658 to 12576 on the plasmid.
This plasmid was a gift from Dr V G Preston.
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Figure 2.2 : The plasmid pFJ3
This plasmid was used in the mutagenesis experiments 
described. The fragment between the two Xbal sites at 
positions 5 and 4122 contains the E. coli Lac Z gene, 
with SV40 early promoter and p o 1yadeny1 ation signals, as 
indi cated.
This plasmid was a gift from Drs F J Rixon and J 
McLauchlan.
6000
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incubator. 1.5 ml of each culture was decanted into a 
sterile eppendorf tube. The tubes were centrifuged for 10 s 
in a bench-top microfuge. The supernatant was discarded and 
the pellet was resuspended in 0.1 ml of STET buffer. The 
tubes were vortexed before addition of 16 ul of lysozyme 
(10 mg/ml in 250 mM Tris—HC1, pH 8.0). The tubes were 
vortexed once more before being placed in a boiling water 
bath for 12 min. The tubes were then centrifuged for 15 min 
in a bench-top microfuge. The supernatant was decanted and 
the plasmid DNA precipitated by addition of 0.1 ml of 
isopropanol. After 10 min the tubes were centrifuged for 3 
min in a bench-top microfuge. The tubes were drained, dried 
and the DNA was resuspended in 50 ul of T E . Clones with the 
expected restriction enzyme patterns were grown up to large 
scale cultures (2.21) and glycerol stocks were made (2.17).
2.21 LARGE SCALE PREPARATION OF PLASMID DNA
100 ml of 2YT broth supplemented with 100 ug/ml
ampicillin was inoculated with 50 ul from the appropriate 
cu Lture
glycerol stockAand shaken overnight at 37°C. This was added 
to 1.6 1 of L-broth and incubated as before until the 
optical density at 550 nm was approximately 0.7 (usually 3- 
4 h ) . The plasmid was amplified by addition of 
chloramphenicol to a final concentration of 1 0 0 ug/ml 
(Clewell, 1972) and the culture was shaken overnight at 
37oC.
The plasmid was isolated by soft lysis, essentially by 
the method of Katz et al. (1973), but with a few minor 
modifications. The amplified bacterial culture was 
centrifuged at 9,000 rpm for 15 min at 4°C. The pellet was 
resuspended in 16 ml of ice-cold 25% sucrose (w/v) in 50 mM
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Tris-HCl pH 8.0. The suspension was distributed to 4 SS34 
tubes on ice and all subsequent procedures were performed 
on ice. Lysozyme was added to each tube to a final 
concentration of 5 mg/ml. After 5 min incubation, 3 ml' of 
250 mM EDTA pH 8.0 was added to each tube, followed by a 
further 5 min on ice. Lysis of the bacterial cells was 
achieved by addition, to each tube, of 9 ml Triton lysis 
solution and incubation on ice for 20 min. After this time 
the lysate was centrifuged at 15,000 rpm at 4°C for 30 min 
to pellet cell debris and chromosomal DNA. The supernatant 
was extracted with an equal volume of TE-buffered phenol 
and the phases were separated by centrifugation at 2 , 0 0 0  
rpm for 10 min. The aqueous phase was decanted into 
dialysis tubing and dialysed against 2 1 of TE for 2 h at 
4°C with 2 changes. After dialysis the" DNA was precipitated 
by addition of 0.1 volumes of 3 M NaOAc and 0.5 volumes of 
isopropanol. The DNA was pelleted by centrifugation at
2,000 rpm for 10 min. The DNA pellet was resuspended in a 
total volume of 5 ml of T E .
The plasmid DNA was purified by isopycnic banding on 
CsCl gradients to remove residual host cell DNA and RNA. 
Gradients were prepared in TE with 1.55 g/ml CsCl and 0.5 
mg/ml ethidium bromide and the centrifugation was performed 
at 40,000 rpm for 18 h at 15oC in a TV865B rotor. The band 
of supercoiled plasmid DNA was visualised under long-wave 
UV radiation (365 nm) and aspirated by needle and syringe. 
The ethidium bromide was removed by extraction with CsCl— 
saturated isopropanol. The plasmid was then dialysed 
against 2 1 of TE at 4<>C for 4 h with 2 changes to remove 
the CsCl. The DNA was precipitated by addition of 2.5 
volumes of ethanol and 0.1 volumes of NaOAc and incubation 
at — 2 0 °C . The precipitate was centrifuged at 9,000 rpm for 
15 min. The pellet was drained, dried and resuspended in TE
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to a final concentration of 0.5 mg/ml and stored at -20oC. 
The yield was generally between 0.2-0.8 mg.
2.22 RESTRICTION ENDONUCLEASE DIGESTION OF PLASMID DNA
Restriction enzymes were used in accordance with the 
suppliers’ instructions, using the buffers provided and at 
the temperature specified.
2.23 ELECTROELUTION OF RESTRICTION FRAGMENTS FROM AGAROSE 
GELS
Restriction fragments of plasmid DNA were separated 
electrophoretically on agarose gels. The digests were 
visualised under long-wave ultra-violet light and the 
band(s) of interest excised in the minimum volume of 
agarose using a sterile scalpel. Each gel slice was placed 
into a dialysis bag, to which was added 200 ul of T B E . The 
bag was sealed, making sure to remove all air bubbles and 
the DNA electroeluted from the agarose at 100 V for 1 h. 
The polarity of the current was reversed for 30 s and the 
TBE (containing the DNA) decanted into a sterile tube. The 
solution was phenol extracted and the aqueous phase 
decanted. The DNA was precipitated under ethanol and 
resuspended in T E .
2.24 LIGATION OF DNA FRAGMENTS
If required, the DNA fragments were blunt-ended using 
T4 DNA polymerase, according to the suppliers’ 
instructions. The DNA samples to be ligated were mixed in 
differing relative proportions, although the total amount 
of DNA was always approximately 0.1 ug. The ligation 
mixture contained; 0.1 ug DNA; 1 ul (2 U) of T4 DNA ligase
^  The specific activity of the [5-3H]dUTP was 21 Ci/mmol.
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5 ul of T4 DNA ligase buffer;200ng of oligonucleotide 
linker (if required) and H20 to 20 ul. The ligation mixture 
was incubated at RT overnight.
2.25 PREPARATION OF DNA CONTAINING TRITIATED dUMP
The assay for uracil-DNA glycosylase depends on release 
of [5-3H]uracil from DNA labelled with [5-3H]dUTP. This DNA 
was prepared by the method of Caradonna and Cheng (1980) as
follows. The reaction mixture (5 ml) consisted of 120 ug/ml
activated calf thymus DNA, 50 mM Tris-HCl, p H 7 .5, 2 mM 
dithiothreito1, 8 mM MgCl2 , 100 ug/ml BSA, 100 uM each of 
dATP, dCTP, dGTP and 20 uM [5-3H]dUTP* The reaction was 
initiated by addition of E. coli polymerase I (fraction 
VIII) and was incubated at 37oC for 60 min. The reaction
was terminated by addition of 20 mM EDTA and then heated to
70oC for 5 min. Unreacted nucleotides were eliminated from 
the sample by dialysis against buffer containing 10 mM 
Tris-HCl, pH 7.5, 1 mM EDTA and 500 mM NaCl. Dialysis was
then continued against the same buffer minus NaCl. The
specific activity of the dUMP-containing DNA was generally 
1 0 - 2 0 , 0 0 0  cpm/ug.
2.26 URACIL-DNA GLYCOSYLASE ASSAY
Assays for uracil-DNA glycosylase activity were 
performed, essentially by the method of Caradonna and Cheng
(1980). The standard reaction mixture (100 ul) contained 50 
mM Tris.HCl, pH 7.5, 2 mM dithiothreitol, 2-3 ug of DNA 
containing dUMP which had been radiolabelled with 3H (10-
2 0 , 0 0 0  cpm/ug, see 2.25 for preparation and labelling), and 
10 ug of BSA. The reaction was initiated by addition of a 
"tenfold dilution of the HSV infected (or mock— infected) 
cell extract (as described in 2.16) and was incubated at
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37°C for 1 h. Termination of the reaction was achieved by 
chilling to OoC followed by addition of 13 ul of sheared 
calf thymus DNA solution (1 mg/ml) and 13 ul of 4 M 
perchloric acid. After incubation at OoC for 10 min the 
samples were centrifuged at 14000 x g for 10 min in a 
benchtop centrifuge. An aliquot of the supernatant (100 ul) 
was transferred to a vial containing Ecoscint scintillant and 
counted in a scintillation counter.
2.27 DNA POLYMERASE ASSAY
The infected and mock-infected cell extracts were also 
assayed for DNA polymerase activity, using the method of 
Keir et al. (1966). The assay mixture (150 ul) was composed 
of the following: 20 mM Tris-HCl, pH 7.5, 8 mM MgCl2 > 200 
mM K C 1 (or 30 mM KC1 if uninfected cellular DNA polymerase 
activity was being measured), 0.4 mM EDTA, 5 mM B- 
mercaptoethano1, 200 uM each deoxyribonuc1eoside 
triphosphate, 2 uCi 3H-TTP and 60 ug denatured DNA (calf 
thymus or salmon sperm DNA, heated at 100oC for 10 min, 
then snap cooled in ice to prevent renaturation) or 60 ul
 _ activated DNA. 20 ul of enzyme preparation (ie extract)
was added to the reaction mixture which was then incubated 
at 31oC for 1 h. The reaction was terminated by immersion 
in an ice-bath. Duplicate 50 ul aliquots were spotted onto 
Whatman No. 1 filter paper discs (2 cm) which were then 
subjected to four 5% TCA washes (5-10 min per wash) and two 
alcohol washes before drying under infra-red light and 
counting on a scintillation counter using Ecoscint as 
scinti1 lant.
2.28 ALKALINE DEOXYRIBONUCLEASE ASSAY
Alkaline deoxyribonuclease assays were performed on the
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extracts, by the method of Morrison and Keir (1968). The 
assay mixture was incubated in a total volume of 1 0 0 ul and 
was comprised as follows: 50 mM Tris-HCl, pH 9.0 (for HSV- 
induced deoxyribonuclease activity), 2 mM MgCl2 , 10 mM B- 
mercaptoethanol, 12.5 ug native BHK C13 DNA and 
approximately A X 105 cpm/assay of 3H-labelled BHK C13 DNA. 
5 ul of a fivefold dilution of the extracts was added to 
the mixture which was then incubated at 31°C for 1 h. The 
reaction was terminated by immersion in an ice-bath. 2 0 0 ug 
of BSA (0.1 ml of a 2 mg/ml stock) was added to each tube, 
followed by 0.3 ml PCA/Hyflo Super Cel (12 mg Hyflo Super 
Cel per 0.6 ml 1 N PCA). The mixture was vortexed and left 
on ice for 10 min before centrifuging at 1,800 rpm for 10 
min on a benchtop centrifuge. 250 ul aliquots of the 
supernatant were decanted into vials containing Ecoscint 
scintillant before being counted.
2.29 DEOXYUPIDINE TRIPHOSPHATASE ASSAY
dUTPase was assayed by the method of Wohlrab et al. 
(1982). HSV-1 infected and mock-infected cell monolayers 
(50 mm plates containing 5 x 106 cells/plate) were washed 
with cold PBS before being hypotonically disrupted in 
buffer comprising 20 mM A- (2-hydroxethy1)-1-piperazine 
ethanesulphonic acid buffer (HEPES), pH 7.8, 1 mM 
dithiothreitol, 1 mM MgCl2 . Hypotonic lysates obtained by
this method, containing 2 x 107 cells in 150 u l , were 
diluted eightfold in the same buffer. The resulting 
suspension was treated with Nonidet P—A0 (final 
concentration 0 .2% v/v) on ice for 20 min and centrifuged 
at 500 x g for 10 min. The supernatant was made 80 mM in 
potassium acetate and clarified by centrifugation at 2 0 , 0 0 0  
x g for 30 min; this constituted the soluble (cytoplasmic) 
fraction. The nuclear pellet was washed with 20 mM HEPES,
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pH 7.8, ImM dithiothreitol, 1 mM MgCl2 and suspended in the 
same buffer containing 80 mM potassium acetate at 2 x 107 
nuclei per 300 u l . dUTPase assay mixture contained in a 
total volume of 50 u l : 40 ul of enzyme fraction, 10 mM 
MgCl2 > 1 mM dithiothreitol, 1 mM ethylene glycol-bis(B- 
aminoethyl ether)-N,N ,N N - t e t r a a c e t i c  acid (EGTA), 2 mM 
ATP, and 1 mM [3H]dUTP (0.1 Ci/mM). The reaction was 
performed at 4°C and was terminated by addition of 20 ul of 
100 mM EDTA and 105 ul of methanol. Aliquots of the 
resulting mixture were applied to pre-washed
polyethyleneimine-cellulose strips together with unlabelled 
marker nucleotides. The strips were developed at room 
temperature with 1 M HCOOH, 0.5 M LiCl and dried. The 
position of the deoxynuc1eotides was determined under UV 
light. Formation of 3H-labelled dUMP was monitored by 
liquid scintillation counting of the corresponding spots 
cut from the chromatogram without prior elution (Wohlrab 
and Francke, 1980).
2.30 RADIOLABELLING OF HSV-1 INDUCED POLYPEPTIDES
Confluent monolayers of BHK C13 cells were either mock- 
infected or infected at a moi of 20 pfu/cell in 0 . 2 ml of 
ETC10. The cells were incubated at 37oC for 1 h before the 
inoculum was removed, the cells were washed twice with 
Eagle’s medium with reduced methionine before being 
overlaid with 2 ml of same. At 2.5 h pi, 100 uCi of 35S— 
methionine was added directly to the medium. At 16 h post- 
infection the medium was aspirated and the cells were 
harvested by addition of boiling mix (see section 2.4) 
diluted 1:2 in H 2 0. The extracts were heated to 80oC for 5 
min and stored at — 20°C until use. Immediately prior to use 
the extracts were boiled for 10 min.
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2.31 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS
Infected cell extracts prepared as described in 2.30 
were subjected to SDS—Polyacrylamide gel electrophoresis 
(SDS-PAGE) in vertical, discontinuous, single concentration 
gels. Fresh stocks of 30% acrylamide were prepared in H 2 O, 
with the ratio of acrylamide to N ,N ’-methylene 
bisacrylamide being 29.25:0.75 respectively. The stock was 
then filtered through Whatman No. 1 filter paper before 
use. The stock was used to give the desired acrylamide 
concentration in gels in resolving gel buffer giving the 
final concentration 375 mM Tris-HCl, pH 8 .9; 0.1% SDS. 
Polymerisation was initiated by addition of 200 ul of 10% 
(w/v) ammonium persulphate and 10 ul of TEMED> per 24 m l ^ f  
gel solution.
The gel solutions were poured between two well-washed 
glass plates separated by 1.5 mm spacers and sealed with 
teflon tape to within 4 cm of the top of the plates. Butan- 
2-ol was layered on top of the gel solution until the 
latter polymerised. The butan-2-ol was removed and a 5% 
acrylamide stacking gel was added, into which was placed a 
teflon well-forming comb.
Samples (50 ul) were applied to the gel, which was run 
overnight at 15 mA in tank buffer.
Following electrophoresis gels were fixed for 1 h 
before being agitated through several successive changes of 
destain. They were then gently agitated in 3 volumes of 
En3Hance (New England Nuclear) for 1 hr before being washed 
twice in 10 volumes of H 2 O for 15—20 min. The gels were 
dried under vacuum onto Whatman grade 182 filter paper and 
exposed to Kodak X—Omat XS— 1 film at —70°C.
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2.32 AGAROSE GEL ELECTROPHORESIS
Masking tape was applied around all four edges of 163mm 
x 264mm glass plate. This was placed on a levelling board 
and made horizontal. Agarose was dissolved in TBE and 
cooled to 50oC. If required, ethidium bromide was added to 
a final concentration of 0.5 ug/ml. The gel was poured and 
allowed to set after insertion of a teflon comb. Once set, 
the masking tape was removed and the gel was placed into 
the horizontal gel electrophoresis apparatus. TBE was added 
up to the level of the top of the gel. Samples were mixed 
with 0.25 volumes of DF dye before loading into the wells 
and were e 1ectrophoresed at 40 V overnight.
For investigation of plasmid preparations, restriction 
digests, etc. a minigel apparatus was used. A gel 
comprising 50 ml of a 1% agarose in TBE with 0.5 ug/ml EtBr 
was cast in the apparatus, where it was e 1ectrophoresed for 
approximately 1 h at 50 V. In both cases the samples were 
visualised by exposure to uv light. For analytical gels 
short wave uv light was used. For preparative purposes, 
long wave uv was used.
2.33 IODINATION OF SYNTHETIC OLIGOPEPTIDES USING Nall 2 5
The iodination procedure is a modification of the 
procedure of Hunter and Greenwood (1962). 10 mg of each 
synthetic oligopeptide was dissolved in 1 0 0 ul of potassium 
phosphate buffer, pH 7.5. 100 uCi of Nal125 and 50 ul of 
chioramine T were then added. This was incubated at RT for 
20 s, after which the reaction was stopped by the addition 
of 50 ul of sodium metabisulphite. Removal of the free 
Nall 25 was achieved by passage through a Sephadex G10 
column preblocked with 0.1% BSA in 0.16 M borate, pH 9.0
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and equilibrated in 0.16 M borate, pH 9.0; 0.13 M NaCl. 
Iodinated oligopeptide was eluted with the equilibration 
buffer. 0.5ml fractions were collected and analysed in a 
gamma counter. The fractions containing the iodinated 
peptide were pooled and, unless used immediately, were 
stored at -70°C.
The iodination reactions were performed by Dr Christine 
MacLean.
2.34 PREPARATION OF BIS-DIAZOTISED BENZIDINE (DAB)
Bis-diazotised benzidine was prepared according to the 
method of Likhite and Sekar (1967). 0.23 g of benzidine 
hydrochloride was dissolved in 45 ml of 0.2 M HC1. 5 ml of 
0.5 M sodium nitrite was added and the solution was stirred 
slowly for 1 h at 4oC. The DAB was then aliquoted in 2 ml 
lots and stored at -70°C until use.
Benzidine hydrochloride and its derivatives are highly 
toxic and therefore preparation of DAB was performed by Dr 
Howard Marsden.
2.35 LINKAGE REACTION
The coupling reaction was performed according to the 
method of Bassiri et al. (1979). 30 mg of BSA was dissolved 
in 1.5 ml of iodinated peptide (approximately 10 mg) in 
0.16 M borate, pH 9.0; 0.13 M NaCl. 1 ml of DAB was added 
and the reaction was left to proceed at 4°C for 2 h. Free 
and coupled oligopeptides were separated by passage through 
a Sephadex G25 PD10 column. Samples were eluted with PBS 
and 10 drop fractions (approximately 0.5 ml) were collected 
and assayed in a gamma counter. BSA—coupled oligopeptide
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was eluted in the void volume and the relevant fractions 
were pooled, dialysed extensively against PBS A to remove 
residual DAB and stored at -70oC until use. The coupling 
efficiency is expressed as a percentage of the total 
radioactivity loaded.
2.36 PRODUCTION OF ANTISERA TO SYNTHETIC OLIGOPEPTIDES
Antisera to the synthetic oligopeptides were raised in 
New Zealand White rabbits. Immunisation, boosting and 
terminal bleeding of the animals was carried out by Serotec 
Ltd.
Antibodies to BSA were removed by adsorption against 
BSA coupled to Sepharose before the sera were tested by 
immunoblotting for reactivity against the appropriate 
protein.
2.37 IODINATION OF PROTEIN A
Protein A (Sigma) was reconstituted in PBS at a 
concentration of 0.5 mg/ml, aliquoted into 20 ul amounts 
and stored at -70oC until use. To 20 ul (10 ug) of protein 
A was added, consecutively, 10 ul of potassium phosphate 
buffer, pH7.5; 200 uCi of N a l i 2 5 ;  and 20 ul of chloramine T
(0.5 mg/ml in PBS). The reaction was left for 20 s at RT 
before the reaction was stopped by the addition of 20 ul of 
sodium metabisulphite (1 mg/ml in PBS). Free N a l * 2 5  was 
removed by passage through a Sephadex G25 PD10 column. The 
iodinated protein A was eluted with PBS in 0.5 ml 
fractions. 10 ul samples of each fraction were assayed in a 
gamma counter and fractions containing the iodinated 
protein A were pooled and stored at 4°C in the presence of 
0.01% sodium azide.
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The iodination reactions were performed by Dr Christine 
MacLean.
2.38 IMMUNOBLOTTING
Immunoblotting was carried out essentially by the 
method of Towbin et al. (1979) but with several 
modifications. Infected cell extracts were prepared as 
described above and subjected to SDS-PAGE. Following 
electrophoresis, the proteins were transferred to 
nitrocellulose strips using a BioRad "Transblot" apparatus, 
used according to the manufacturer’s instructions. Into a 
transfer cassette immersed in transfer buffer was placed a 
foam pad, followed by a sheet of Whatman grade 182 filter 
paper and then the gel. On top of this, numbered 
nitrocellulose strips, presoaked in transfer buffer, were 
placed face down on the gel, being careful to exclude air 
bubbles. Another sheet of filter paper and finally another 
foam pad were placed on top. The cassette was tightly 
closed and inserted into the transfer tank. The proteins 
were transfered onto the nitrocellulose by electrophoresis 
in transfer buffer at 250 mA for 3 h at R T .
Following transfer the nitrocellulose was blocked by 
agitation at 37oC for 2 x 30 min in small tubs containing 
TBS supplemented with 3% gelatin. After this time, the 
strips were rinsed twice in wash buffer containing 0.05% 
Tween 20. The strips were then ready to be incubated with 
the antisera. The antisera were first preabsorbed against 
BSA-Sepharose to remove anti-BSA antibodies before being 
diluted tenfold with wash buffer supplemented with 0.05% 
Tween 20 and 1% BSA. 3 ml of each antiserum was dispensed 
into channels cut into a perspex block. The strips were
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placed face up in the channels and covered with a glass 
plate before being incubated at RT overnight on a rotary 
shaker. The strips were removed and agitated in wash buffer 
with 0.05% Tween 20 for 4 periods of 30 min. The strips 
were then transferred into the channels of another perspex 
block into which had first been dispensed 3 ml of wash 
buffer with 0.05% Tween 20 and 500,000 cpm of 1125—protein 
A. A glass plate was placed over the block, which was then 
agitated for 2 h at RT. The strips were then washed for 2 
periods of 30 min in wash buffer containing 1 M KI and then 
2 x 15 min washes with PBS. The strips were placed on 
tissues to dry and then taped to cardboard sheets for 
autoradi ography.
To determine which of the S3 5-methionine labelled 
proteins the 1125-1abe11ed protein A interacted with, the 
protocol of Haarr et al. (1985) was employed. Using this 
procedure the strips were used to simultaneously expose 3 
films in an autoradiographic sandwich. One film was placed 
directly on top of the card to which the strips were taped. 
Over this was placed a sheet of black paper followed by a 
further two sheets of film and an image intensifying 
screen. Thus, the first film detects the S3 5-methionine 
label which does not penetrate as far as the second film. 
The 1125 label, which is of higher energy, passes through 
all three films with little absorption and interacts with 
the image intensifying screen to produce photons. These 
photons are detected mainly on the third film and partly on 
the second film. The photons are prevented from reaching 
the first film by the black paper. Alignment of the films 
was facilitated by spotting radioactive ink, containing Cl* 
and 1125, onto the card.
RESULTS AND DISCUSSION
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3.1 RECOMBINANT PLASMIDS
3.1.1 pFJ3
The DNA fragment which was used in the insertion 
mutagenesis work described in this thesis originated from 
the plasmid pFJ3. The structure of this plasmid, which was 
supplied by Drs Frazer Rixon and John McLauchlan, is shown 
in figure 3.1. The LacZ gene in this plasmid is under the 
direction of the SV40 early promoter (Hall et al., 1983). 
The relevant moiety is the part numbered 5 to 4122, between 
the two Xbal sites. This fragment contains the LacZ 
indicator gene and was used to construct pJM3 and pJM4. 
pJM3 and pJM4 were used in the insertion mutagenesis 
experiments and their construction is described later. pFJ3 
was digested with Xbal and the two resultant fragments were 
separated by electrophoresis on an agarose gel. The 
fragment containing the LacZ gene was purified by 
electroelution and used in the construction of pJM3.
3.1.2 pGX23
All manipulations involving the HSV-1 genes UL2 and UL1 
were first performed on plasmid-borne copies of the genes. 
The plasmid pGX23 contains the HSV-1 BairHI e fragment 
ligated into the Baniil site in pAT153. This fragment of 
HSV-1 is from residues 2907 to 11820 of the virus genome 
(McGeoch et al., 1988) and contains the genes UL1, UL2 and 
U L 3 . The plasmid is shown diagrammatically in figure 3.2.
3.1.3 pJM3
The plasmids pFJ3 and pGX23 were used in the 
construction of pJM3, which is shown in figure 3.3 and was
Figure 3.1 : The plasmid pFJ3
This plasmid was used in the mutagenesis experiments 
described. The fragment between the two Xbal sites at 
positions 5 and 4122 contains the E. coli Lac Z gene, 
with SV40 early promoter and polyadenylation signals, as 
indi cated.
This plasmid was a gift from Drs F J Rixon and J 
McLauchlan.
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Figure 3.2 The plasmid pGX23
The plasmid pGX23 was used to construct the 
mutations described in this section. The structure of the 
plasmid is depicted in this figure. pAT153 sequences 
extend from position 1 to 3657, and the HSV-1 BanMI e 
fragment (residue 2907 to 11820 in the virus genome) is 
from position 3658 to 12576 on the plasmid. The positions 
of genes U L 1 , UL2 and UL3 are indicated.
This plasmid was a gift from Dr V G Preston.
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constructed as follows. The Xbal fragment from pFJ3
blunt—ended and 
containing the LacZ gene was/\ligated into the Xbal site in
the plasmid pGX23. This site is within the coding sequence
of the UL2 gene, (McGeoch et al.f 1988). The ligation
mixture was used to transform competent E. coli DH5 on L-
broth agar plates containing X-gal and ampicillin.
Bacterial colonies transformed with a plasmid containing
the LacZ gene were blue on these plates. Restriction
analysis using the enzymes Xbal, BarrH I, EcoRl and PstI
confirmed the structure of pJM3 and indicated the
orientation of the insert within the gene. pJM3 was
subsequently used in the construction of the recombinant
viruses inl601 and inl602.
3.1.A pJM4
The plasmids pGX23 and pFJ3 were also used to construct 
the plasmid p JM4 , which is shown in figure 3.4. pGX23 has a 
Hpal restriction site within the coding sequence of UL1. 
There are two other Hpal site in pGX23, which were removed 
by digestion with Notl and religation of the large 
fragment, containing the remaining Hpal site. The LacZ 
fragment from pFJ3 was inserted into this unique Hpal site 
and the ligation mixture was used to transform competent E. 
coli DH5 on L—broth agar plates containing X-gal and 
ampicillin. Colonies which had been transformed by the 
plasmid were blue on these plates. The structure of the 
plasmid was confirmed by restriction analysis, using the 
enzymes EcoRl, Hpal, Pstl and Hindlll. This plasmid was 
then used in the construction of the recombinant virus 
in!603.
Figure 3.3 : The plasmid pJM3
This plasmid used to engineer the mutations in UL2 
present in the recombinant viruses inl601 and inl602, and 
was constructed by insertion of the appropriate Xbal 
fragment of pFJ3 into the unique Xbal site in the UL2 
coding region. The positions of the HSV-1 genes and the 
insert are shown.
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3.2 RECOMBINANT VIRUS in!601
3.2.1 COTRANSFECTION AND PURIFICATION
The plasmid pJM3 was digested with the restriction 
enzyme jBstEII. The fragments were separated by 
electrophoresis on an agarose gel and the appropriate 
fragment was recoved by electroelution. This fragment was 
used with wt HSV-1 DNA in the cotransfection which gave 
rise to the mutant inl601.
The progeny from the initial cotransfection were
titrated as described* ___________
s A 11 el even blue 
plaques from the initial titration were picked and 
titrated. In
subsequent rounds of plaque purification, ten blue plaques 
were picked and carried forward*
The recombinant plaqued as well as wt. Plaque 
purification continued until all the progeny exhibited the 
recombinant phenotype. At this stage a single, isolated 
blue plaque was picked and used to generate a high-titre 
elite stock, designated inl601. This stock had a titre of 5 
X 109 pfu/ml and was used in all subsequent experiments 
involving inl601. In tissue culture this virus grew as well 
as wt, in that plaques picked from both viruses yielded 
similar numbers of progeny (see also section 3.2.2).
Plaques from inl601 are indistinguishable from those caused 
by infection with wt, with the exception that the former 
stain blue when grown under X-gal.
Isolation of the recombinant was facilitated by the 
phenotype conferred on it by the indicator gene.
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The frequency of 
recombination in this case may be as low as 1 in 10^ or 
less. This is lower (by at least two orders of magnitude) 
than the frequency of recombination reported by others. For 
example Ace et al. (1989) reported isolation of a mutant of 
HSV-1 which contains an insertion in UL48, the gene which 
encodes the virus trans-inducing factor, Vnw65. Their 
reported recombination efficiency was 1 mutant in 84 plaque 
isolates screened. However, in this case the insert was a 
12 bp oligonucleotide. In the construction of dut-1218, a 
recombinant virus used later in this study, the 
recombination efficiency was estimated as approximately 1% 
(V G Preston, personal communication). Once again the 
insertion was of a small (8 bp) oligonucleotide. In the 
case of inl601, recombination may have been impeded by 
potential spatial constraints imposed by the relatively 
large (4.1 kbp) insert. Since the resulting mutant (inl601) 
subsequently showed no signs of impairment in its growth, 
it can be assumed that the low recombination frequency was 
not due to a secondary dysfunction (ie reduced viability of 
the mutants brought about by the mutation) , but may be as a 
result of the low probability of a recombination event 
occurring on both sides of the insert. Addition of X-gal to 
the growth medium does not restrict the growth of wt virus 
and so there is no selection pressure which would 
preferentially encourage growth of the recombinant progeny. 
However, the ease with which recombinants can be recognised 
compensates for the low recombination frequencies obtained 
with such a large insert.
The genome of inl601 was verified by restriction 
endonuclease digestion, as described in section 2.13. The 
restriction enzymes used in this analysis were Xbal, BaniII, 
BglII, and Hindlll. The effects brought about by the
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mutation on the restriction profile of each of these 
enzymes is discussed in turn. In each case, the alterations 
are discussed first with respect to the prototypic 
orientation of the genome, followed by the effects due to 
orientation isomerisation.
a) Xbal
The insert is bounded by Xbal sites and has been
inserted at the Xbal site between the g and c fragments.
The predicted effect of the mutation in this case would be 
the appearance of a novel band (N), 4.1 kbp in size. All
the other fragments should be identical to their wt
counterparts. A partial Xbal restriction map of wt and 
inl601 (both in the prototypic orientation) is shown in 
figure 3.5.
The phenomenon of orientation isomerisation means that 
some restriction fragments only exist in certain 
orientations of the genome. Since g is a terminal fragment 
in the prototypic arrangement, it is only present in the 
prototype and Is orientations. In the other two 
arrangements of the genome (II and Isl)> S is combined with 
the short segment of the genome (there are no Xbal sites in 
this segment) to become the b fragment. Therefore, any 
changes in the g fragment will also be reflected in the b 
fragment. However, in the case of inl601, the g fragment is 
still intact, as is the Xbal site between it and the c 
fragment, and so the mutation does not affect fragments 
which are present in orientations other than the prototype.
Figure 3.6 is an autoradiograph of the Xbal restriction 
profiles of wt and inl601 DNA. The figure demonstrates that 
the only genotypic change brought about by the insert
Figure 3.5 : Partial Xbal restriction maps of wt and
ini 601
The relative positions of Xbal restriction sites at 
the left end of the prototypic virus genome in both wt 
and inl601 are indicated. The wt genome has only one site 
in this region (the site of insertion). The genome of 
inl601 has an extra Xbal site, brought about by the 
insertion, therefore digestion with Xbal will give rise 
to a novel restriction fragment, N, corresponding to the 
insert, which is shown as a thick line.
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Figure 3.6 : Xbal restriction profiles of wt and inl601
Figure 3.6 is an autoradiograph of wt and inl601 DNA 
digested with Xbal and separated on a 1.2% agarose gel. The 
wt has a normal restriction profile. The profile obtained 
from inl601 is the same as wt, with the exception of a 
novel band, N, which corresponds to the insert and migrates 
below g.
insert
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appears to be the presence of a novel restriction fragment
(N) which migrates below g, and is of the predicted
mobility.
b) BanHI
The LacZ insert contains one BanHI site and has been 
inserted into the HSV-1 BanHI e fragment. The predicted 
changes from the wt genotype are :
The e band in wt HSV— 1 is 8.9 kbp long. Insertion of 
the mutating DNA increases the length of e by A .1 kbp. The 
insertion of this fragment introduces a novel Bam HI 
restriction site, such that cleavage by BanHI should show 
the disappearance of the truncation of the e fragment to 
e' , and the appearance of a novel fragment, N. Changes in 
the e fragment should not be accompanied by changes in any 
of the other fragments, as the e fragment is not located at 
either of the termini or at the L-S junction. Figure 3.7 is
a partial BanHI restriction map of the prototype
orientations of wt and inl601 DNA.
The autoradiograph (figure 3.8) displays the BanHI 
restriction profiles of wt and inl601. The differences 
between the two profiles are as predicted ie the e fragment 
has been truncated to the fragment e’ and a novel fragment, 
N, of the predicted mobility. This is observed in the 
inl601 track but not in the wt track.
c) Bglll
The mutagenising fragment has been inserted into the 
Bglll J fragment and contains one Bglll site. The predicted 
alterations in the prototype isomer of the genome, due to 
the insertion are :
Figure 3.7 : Partial BamHI restriction maps of wt and
inl601
This figure depicts the BanHI restriction sites 
found in this region of the wt and inl601 genomes. The 
insert, which is represented by a thick line, introduces 
a novel BanHI site into the genome of inl601, which 
results in the appearence of a novel restriction 
fragment, N, into its restriction profile. This novel 
BanHI site truncates the e fragment by 0.9 kbp, to e ‘.
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Figure 3.8 : BanHI restriction profiles of wt and in!601
The BanHI restriction profiles of DNA derived from 
wt and inl601 virus is shown opposite. The wt genome 
exhibits a normal restriction profile. In the inl601 
profile, the e fragment is replaced by the truncated e ’ 
fragment, and there is a novel fragment, N, not present
in the wt track. These changes are as predicted. The 
restriction fragments were separated on a 0.7% agarose gel.
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The Bgl II j fragment is 14.6 kbp in length and the 
insert increases the size of j by 4.1 kbp. The insert 
introduces one new BglII site into the j fragment. 
Digestion of inl601 with BglII should therefore give rise 
to the truncation of the j fragment to j' , and to the 
appearance of a novel band N. Figure 3.9 is a Bglll 
restriction map of the two viruses in the prototypic 
orientat ion.
Because of the existence of the four sequence-
orientation isomers, changes in the j fragment will also
affect the b and e fragments, which include j and are seen 
only in the other genome arrangements. These two fragments 
will be replaced by the fragments b’ and e* , respectively, 
and will also be accompanied by a novel band N, identical 
to the novel fragment accompanying the j' fragment.
The autoradiograph figure 3.10 shows the fragments 
obtained by digestion of wt and inl601 DNA by Bglll. The 
band corresponding to the j fragment is absent in the 
inl601 profile. However, the predicted band of lower 
mobility, corresponding to the truncated j fragment cannot 
be discerned. This band, the j* fragment is predicted to be
10.6 kbp in length, which is approximately the same size as
the k fragment, which is also 10.6 kbp. It. is expected that 
these two bands would therefore comigrate. Because j is a 
terminal fragment, it is represented in half—molar amounts, 
with respect to jk. This would limit the increase in the 
intensity of the band representing the k + j* fragments.
The b and e fragments are also truncated in the mutant, but 
again the truncated bands (b’ and e’ respectively) are not 
visualised, due to their comigration with the c and f 
bands, respectively. Both b and e are quarter-molar bands 
and so the changes in the intensities of the c and f bands
Figure 3.9 : Bglll restriction maps of wt and inl601
As can be seen from this figure, the insert is 
located within the BglII j fragment, and introduces a 
novel BglII restriction site into this fragment, 
truncating it to the fragment J ’. The introduction of the 
novel BglII site also results in the presence of a novel 
restriction fragment, N. j is a terminal fragment and as 
such is only present in two arrangements of the genome 
(prototype and Is). In the other two arrangements, j is 
incorporated into the b and the e fragments. 
Correspondingly, the mutation, which truncates j, will 
also truncate b and e, to b’ and e* , respectively, and in 
both cases this will also be accompanied by the 
appearance of the novel fragment, N.
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Figure 3.10 : Bg lII restriction profiles of wt and in!601
In the case of digestion with Bglll , some of the 
changes brought about the mutation are noticeable, but 
others are difficult to see. The novel band, N, is very 
obvious, as is the disappearence of the j, b and e 
fragments. However, it is difficult to discern the 
truncated j ’, b9 and e ’ fragments. In the case of j ’, 
which being a terminal fragment, is half molar, the 
truncated fragment is the same size as another fragment, 
k, and therefore comigrates with it. k is a molar band 
and so it is difficult to determine any increase in 
intensity brought about by the half-molar J 9 fragment.
The same is also true of b9 and e 9 , which are also half- 
molar and comigrate with the fragments c and- f, 
respectively. The restriction fragments were separated on a 
0.8% agarose gel.
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are even more difficult to see than the increase in the k 
band. The novel band (N) , composed of the insert plus part 
of the J fragment is seen migrating between the 1 and m 
bands, which is as expected. It is the case that all the 
differences observed in the mutant are as predicted.
d) Hindlll
The insert, which has two Hindlll sites, has been 
inserted into the Hindlll i fragment. The predicted changes 
in the Hindlll restriction profile of the prototypic 
orientation are :
The i fragment is 12.7 kbp in length and the insert 
increases this by 4.1 kbp. The insert contains two Hindlll 
sites, separated by 3.7 kbp. Digestion of inl601 by Hindlll 
should give rise to truncation of the i fragment by 2.1 kbp 
to i’ , and to the appearence of two novel bands (N1 and 
N2), 3.7 kbp and 2.4 kbp in length respectively. Figure 
3.11 is a partial Hindlll restriction map of prototypic wt 
and inl601. i is a terminal fragment and so is only found 
in the prototype and Is arrangements of the genome. In the 
other two orientations, i is incorporated into the e and f 
fragments, respectively. Thus, the mutation will also 
affect the e and f fragments, which will be truncated to e> 
and f’ , respectively. These fragments will also be 
accompanied by the two novel bands N1 and N2.
The autoradiograph of the restriction profiles of both 
viruses digested with Hindlll (figure 3.12) demonstrates 
the altered mobility of the i, e and f bands to i’ , e and 
f’ respectively (although in this figure, the i fragment 
cannot be distinguished, due to its comigration with h, 
which is of a similar size and is present in molar amounts 
as opposed to i, which is only half molar). These bands are
Figure 3.11 : Hindlll restriction maps of wt and inl601
This figure shows the location of the insert in the 
prototype arrangement of the genome, and the locations of 
the Hindlll sites. The insert is located within the i 
fragment and introduces two novel Hindlll sites into the 
genome. This results in the truncation of i to i’, and 
the appearence of two novel restriction fragments, N1 and 
N2. i is a terminal fragment and as such is only present 
in two arrangements of the genome (prototype and Is)• In 
the other two arrangements, i is incorporated into the e 
and the f fragments. Correspondingly, the mutation, which 
truncates i, will also truncate e and f, to e* and f* , 
repectively, and in both cases this will also be 
accompanied by the appearence of the two novel fragments, 
N 1 and N2.

Figure 3.12 : Hindlll restriction profiles of wt and
in!601
Figure 3.12 is an autoradiograph of DNA prepared 
from wt and inl601 virus, and digested with Hindlll. The 
wt profile is as expected; the i fragment co-migrates 
with h and so cannot be observed. However, i5 can be seen 
in the inl601 profile, as can e f , f* and the two novel 
bands, N1 and N2, which are all of the predicted
'mobility. The restriction fragments were separated on a 1% 
agarose gel.
w t in 1601
■ I  
— * . s
*****
J  f  — S i
s a 1 •
MMBril
1 B
S B *
N 1 ---- JMHS*'
N 2 ----
75
of the predicted mobility, as are the two novel bands (N1 
and N2) indicated.
All of these profiles together confirm that the insert 
has been introduced at the predicted location and that no 
other rearrangements are to be found in the genome of 
inl601. There have been reports of insertional mutagenesis 
by homologous recombination in HSV-1 giving rise to genome 
rearrangements other than those predicted. Longnecker and 
Roizman (1986) attempted to recombine a DNA fragment 
containing part of the HSV-1 IE175 gene and a copy of Oris 
into the TK gene. Analysis of the progeny revealed 
extensive, unpredicted rearrangements and deletions in Us 
and in the L/S junction sequences. However, the authors 
have attributed this phenomenon to the inclusion of some 
cis-acting signal which was detrimental to the growth of 
the recombinant and bestowed a selective advantage to 
mutants arising spontaneously. Pogue-Geile et al. (1985) 
reported the isolation of mutants of HSV-1 exhibiting 
unpredicted rearrangements after cotransfecting DNA from 
the HSV-1 BarrHI 1 fragment into the TK gene. Presumably 
these rearrangements are a result of recombinational events 
between the sequences which are duplicated by the insertion 
of HSV-1 DNA. In the present study, the DNA used in the 
mutagenesis was not derived from the virus and so 
presumably there was not the same potential for 
recombinational rearrangements as there were no novel 
duplications in the genome of the progeny.
3.2.2 PROPERTIES OF THE RECOMBINANT in!601
i Growth
After the authenticity of the genome had been
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established, the mutant was subjected to a phenotypic 
investigation. The first part of this was an examination of 
the growth characteristics of this virus.
. The one-step growth curve 
shows the development of virus infection over a set period 
of time (24 hours) from a fixed inoculum (5 pfu/cell). The 
results obtained are displayed in figure 3.13. The graph 
shows that, under the conditions of the assay, growth of 
inl601 does not differ significantly from that of wt.
The experimental data presented so far confirm that an 
insertion mutation has been engineered into the UL2 gene 
and that the product of that gene is not absolutely 
required for normal growth, at least in the tissue culture 
system used in this study.
ii Enzyme assays
a) Uracil-DNA glycosylase
As was stated earlier, the primary candidate for the 
HSV induced uracil-DNA glycosylase activity, was the 
product of gene UL2. Once the insertion mutant had been 
constructed and its genome verified, the next step was 
determination of the uracil-DNA glycosylase activity of the 
mutant. Extracts were prepared from cells mock—infected or 
infected with wt or inl601 at 10 h pi as described in 
section 2.16. These extracts were assayed for uracil-DNA 
glycosylase activity as described in section 2.26. The 
principle of the assay is the release of [5-3H]uracil from
Figure 3.13 : One step growth curves
Opposite is displayed the one step growth curves 
obtained for wt and inl601. The monolayers were infected 
at 5 pfu/cell and plates were harvested at 1, 2, 3, 4, 6, 
8, 10, 12, 21 and 25 h pi, before being titrated on 
confluent monolayers of BHK C13 cells on 35 mm plates.
All titrations were performed at 37oC.
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DNA which had been prepared containing [5-3H]-dUMP (see 
section 2.25). The assays were performed in the presence of 
EDTA, which inhibits exonuclease activity. The levels of 
uracil-DNA glycosylase activity in these extracts are shown 
in figure 3.14. This figure shows a readily measurable 
level of uracil-DNA glycosylase activity in the extract 
prepared from cells infected with wt, with the level of 
activity in the mock-infected cell extract being much 
lower. There was no significant difference between the 
level of activity in the extract from cells infected with 
inl601 and the mock extract, indicating that this virus 
does not induce uracil-DNA glycosylase activity.
b) Other enzyme activities
In order to ensure that the low level of uracil-DNA 
glycosylase activity induced in cells infected with inl601 
was not due to a reduced level of infection, two more 
enzyme activities were measured. The first of these was 
that of the HSV-induced alkaline exonuclease enzyme. The 
extracts used in the uracil-DNA glycosylase assays above 
were used in exonuclease assays which were performed in the 
absence of EDTA but at a pH of 9.0, which has been shown to 
inhibit any cellular exonuclease activity (Morrison and 
Keir, 1968). The level of alkaline exonuclease activity 
present in these extracts at 10 h pi is presented in figure 
3.15. In this case, the levels of exonuclease activity in 
the extracts from wt and inl601 infected cells were very 
similar to each other, and the activity from the 
mock—infected extract was essentially zero. This indicates 
that the infection with inl601 was as productive as that 
with wt, and the low level of uracil-DNA glycosylase 
activity shown in the inl601 infected extract was not due 
to a reduced level of infection.
Figure 3.14 : Uracil-DNA glycosylase assays
Extracts prepared at 10 h pi were assayed for 
uracil-DNA glycosylase activity as described. The results 
of these assays are presented graphically. The enzyme 
activity present in each extract is displayed along the 
ordinate axis, as amount of radioactivity released/mg 
protein. The activities of extracts prepared from cells 
mock-infected, or infected with wt or inl601 virus are 
shown.
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Figure 3.15 : Other enzyme assays
Extracts prepared at 10 h pi were assayed for 
alkaline exonuclease, DNA polymerase and dUTPase activity 
as described. The results of these assays are presented 
graphically, on graphs a, b and c, respectively. The 
enzyme activity present in each extract is displayed 
along the ordinate axis, as amount of radioactivity 
released (or incorporated, in the case of the DNA 
polymerase assay)/mg protein. The activities of extracts 
prepared from-cells mock— infected, or infected with wt or 
inl601 virus are shown.
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The second enzyme activity to which the extracts were 
subjected was the virus induced DNA polymerase. The results 
of this assay are also presented in figure 3.15. Once . 
again, there was no significant difference between the 
levels of polymerase activity in the extracts infected with 
wt and those infected with inl601, and the mock infected 
extract had an insignificant level of activity. These 
results corroborate those obtained for the exonuclease 
activities.
One other enzyme assay which was performed on the 
extracts was that for dUTPase. This assay was performed as 
part of the experiment to determine the phenotype of 
another recombinant virus, inl602 (to be discussed later), 
but the results are included here as further evidence of 
the level of infection of the inl601 extract. The results, 
which are also shown in figure 3.15, demonstrate a similar 
profile of activity between the respective extracts as the 
exonuclease and polymerase assays. This can be taken as 
further confirmation of the efficiency of infection with 
inl601.
c) Time course of enzyme assays
In order to investigate the progression of infection in 
cells infected with these viruses, a series of extracts 
were prepared at 3, 6, 9 and 12 h pi. These extracts were 
assayed for the four enzyme activities described above. The 
results are displayed in figure 3.16. In general, the time 
courses show that, with the obvious exception of
uracil-DNA glycosylase, there is no great difference in the
levels of enzyme activities induced by wt and by inl601.
There does appear to be a small lag in the level of
Figure 3.16 : Enzyme assay time courses
Extracts prepared at 3, 6, 9 and 12 h pi were 
assayed for uracil-DNA glycosylase, alkaline exonuclease, 
DNA polymerase and dUTPase activity as described. The 
results of these assays are presented graphically, in 
graphs a, b, c and d, respectively. The enzyme activity 
present in each extract is displayed along the ordinate 
axis, as amount of radioactivity released (or 
incorporated, in the case of the DNA polymerase assay)/mg 
protein. The activities of extracts prepared from cells 
mock-infected, or infected with wt or inl601 virus are 
shown.
DN
A 
po
ly
me
ra
se
 
act
ivi
ty 
Ur
ac
il
-D
NA
 
gl
yc
os
yl
as
e 
ac
ti
vi
ty
 
(c
pm
/m
g 
pr
ot
ei
n)
/!
00
0 
(c
pm
/m
g 
pr
ot
ei
n)
/!
 0
00
Uracil-DNA glycosylase time course Alkaline exonuclease assay time course
40-
30-
10 -
3 96 12
140
120
100
20 -
2 4 6 8 10 12 14
Time (hours pi) Time (hours pi)
DNA polymerase assay time course
20 “
10 -
-»
2 4 6 8 10 12 14
dUTPase assay time course
60-
50“
wt
inl601
mi
20-
10-
2 4 6 8 10 12 14
Time (hours pi)
Time (hours pi)
79
exonuclease activity induced by inl601, but this is not 
observed in any of the other curves. Also, the lag is 
almost fully corrected by 9 h pi and so is not regarded as 
being significant.
d) Temporal regulation of the UL2 gene
As has already been discussed, HSV genes are regulated 
in three distinct temporal classes. In order to determine 
to which regulatory class UL2 belongs, uracil-DNA 
glycosylase assays were conducted on extracts of cells 
infected with wt HSV-1 in the continuous presence of 
phosphonoacetic acid (PAA), an inhibitor of virus DNA 
synthesis. The results of these assays are presented in 
figure 3.17. As can be seen from the figure, there is no 
significant difference between the levels of uracil-DNA 
glycosylase activity in the presence or absence of PAA.
This indicates that the uracil-DNA glycosylase gene, UL2, 
is regulated as an early gene, i.e. it is transcriptionally 
active before the onset of virus DNA replication. This 
result is not unexpected as all enzyme activities 
concerning DNA replication are present before replication 
commences. For example, TK and RR are examples of early 
genes. Mutation and repair of DNA is a continuous process 
and as such it is advantageous if the level of mutation is 
minimised before replication commences, preventing any 
damage present in the parent molecule from being passed on 
to the progeny.
e) Radio1abe11ed HSV-1 induced polypeptides
In order to discern what effect (if any), the mutation 
had on the proteins induced by inl601, radiolabelled cell 
extracts were prepared from cells infected with wt virus
Figure 3.17 : Temporal regulation of the UL2 gene
Cells which had been pre-treated with PAA were 
infected and incubated in the continuous presence of PAA. 
Extracts were prepared at 10 h pi and assayed for 
uracil-DNA glycosylase activity as described.
The results of these assays are presented graphically.
The enzyme activity present in each extract is displayed 
along the ordinate axis, as amount of radioactivity 
released/mg protein. The activities of extracts prepared 
from cells mock-infected, or infected with wt or inl601 
virus are shown, in the presence and absence of PAA.
Ur
ac
il-
DN
A 
gl
yc
os
yl
as
e 
ac
tiv
ity
 
(cp
m
/m
g 
pr
ot
ein
)/!
 0
00
Uracil-DNA glycosylase assays 
in the presence and absence of PAA
yy\ wt -PAA 
in 1601 -PAA
I mi -PAA 
wt +PAA 
inl601 +PAA 
M  mi +PAA
Infected cell extract
80
and cells infected with inl601 in the presence of 835- 
methionine. These extracts were examined by polyacrylamide 
gel electrophoresis, the results of which are shown in 
figure 3.18. Comparison of these profiles does not result 
in the identification of any specific polypeptide which can 
be assigned as the UL2 gene product, as there are no 
obvious differences between the two profiles, either in 
terms of a qualitative alteration or a modulation in the 
mobility of a specific band or bands. However, these 
profiles are complex and thus changes in minor bands may 
not be detectable by this method.
f) Reaction of virus-infected cell extracts with rabbit 
antisera raised against synthetic oligopeptides
Two synthetic oligopeptides were used to immunise a 
total of four rabbits. The peptide sequences used were 
derived from the amino acid sequence of the UL2 gene 
product and are shown in figure 3.19. Two rabbits (1 and 2) 
were immunised with peptide a and the other rabbits (3 and 
4) were immunised with peptide b. The rabbits were boosted 
with more immunogen every four weeks and bled for testing 
two weeks after each boost. The bleeds were assayed for 
reactivity with virus-infected cell extracts by Western 
blotting. At seven months post-immunisation, the rabbits 
were sacrificed and terminal bleeds were taken. The sera 
from all four rabbits were assayed for reactivity to 
extracts obtained from cells either mock—infected, or 
infected with either wt HSV-1 or inl601. The figures 3.20 
to 3.23 show the reactions of the sera obtained from 
rabbits 1 to 4, respectively, with these extracts. The sera 
from two rabbits (1 and 2) demonstrated reactivity with the 
extracts from cells infected with wt virus and this is 
shown in western blots, figures 3.20 and 3.21. These blots
Figure 3.18 : S3 5 —Methionine labelled HSV induced
polypetides
Figure 3.18 is an autoradiograph of S3 5-Methionine 
labelled virus induced polypeptides. There are no 
discernible differences between the two profiles. Mr are 
as indicated.
inl601
Figure 3.19 : UL2 amino acid sequence
The amino acid sequence translated from the UL2 DNA 
sequence is depicted opposite. The sequences of the two 
synthetic oligopeptides (a and b) are shown.
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show that the sera from rabbits 1 and 2 react specifically 
with extracts from cells infected with wt HSV-1, but not 
inl601. The sera from these rabbits show an increasingly 
strong reaction over a period of months to a maximum at the 
terminal bleed, which was taken 7 months after the initial 
immunisation. None of the pre-immune bleeds from these 
rabbits shows any reaction with any of the extracts, and 
none of the sera incubated with mock-infected extracts show 
any reaction, apart from a few faint bands. There is no 
reaction between these sera and the extracts obtained from 
cells infected with inl601, indicating that the sera are 
reacting specifically with the uracil-DNA glycosylase 
prote in.
There is one major band at Mr 39,000 with three minor 
bands at Mr 31,000, 25,000 and 21,000. The minor bands may 
be processed forms of the major band, but as the majority 
of the activity stays in the major band, it is more likely 
that the minor bands are degradation products of the more 
abundant species. Worrad and Caradonna (1988) estimated the 
Mr of the HSV-2 encoded uracil-DNA glycosylase enzyme to be 
28-35,000 and predicted the Mr of the type 1 enzyme to be 
42,300 although they did not state how the latter was 
calculated. Perry and McGeoch (1988) indicated the 
existence of two possible initiation codons for what was 
then regarded as the UL2 open reading frame (ORF). The 
first of these opens an ORF encoding a polypeptide of 334 
amino acids with a predicted Mr of 36,300, and the second 
opens an ORF of 244 amino acids with a predicted Mr of 
27,300. When the work described in this section was 
published (Mullaney et al., 1989), the authors stated that 
the second methionine may have been the more likely 
candidate. This assumption was made on the basis of 
comparing the amino acid sequences of UL2 with its
3.20 : Immunoblot - Rabbit 1
Extracts from cells mock-infected, or infected wi 
wt or inl601 were separated by SDS-PAGE and transferre 
to nitro-ce1lulose strips as described. Sera from rabb 
1 were reacted with the immobilised extracts as 
indicated. The abbreviations are as follows;
PI - Pre-immune serum
+2 - serum 2 months
+4 - serum 4 months
T - terminal serum
immunisation)
post initial immunisiation 
post initial immunisation 
(7 months post initial

3.21 : Immunoblot - Rabbit 2
Extracts from cells mock-infected, or infected with 
wt or inl601 were separated by SDS-PAGE and transferred 
to nitro—ce11u 1ose strips as described. Sera from rabbit 
2 were reacted with the immobilised extracts as 
indicated. The abbreviations are as follows;
PI - Pre-immune serum
+2 - serum 2 months post initial immunisiation
+4 - serum 4 months post initial immunisation
T - terminal serum (7 months post initial
immunisation)
___________
82
homo 1ogues in VZV and EBV. This assignation was made 
without the benefit of the data obtained from the western 
blots (figures 3.20 and 3.21). The blots show that the 
protein has a Mr more consistent with transcription 
initiating at the first ATG codon, although it possible 
that the native protein could be smaller but is modified 
post—trans1ationa11y . However, no conclusive assignment can 
be made with the data available at present.
The sera obtained from the other two rabbits (3 and 4) 
showed no reactivity with extracts prepared from cells 
infected either with wt or inl601 (figures 3.22 and 3.23). 
Once more there are a few faint bands, but these are not 
regarded as having any significance. These sera were 
obtained from rabbits which had been immunised with the 
other synthetic oligopeptide, b. This amino acid sequence 
was used as it is part of a motif which is conserved among 
the herpesviruses.
3.2.3 COMPARISON OF THE HSV-1 UL2 GENE PRODUCT AMINO ACID 
SEQUENCE WITH ITS HOMOLOGUES
Throughout the Herpesviridae there are many examples of 
genes being conserved between members of different sub­
families (for examples see McGeoch et al., 1988).
Comparison of the HSV-1 UL2 amino acid sequence with the 
proposed amino acid sequences in other human herpesviruses 
shows that there are UL2 homologues in all the other human 
herpesviruses whose genomes have been sequenced (ie HSV-2, 
Worrad and Caradonna, 1988; VZV, Davison and Scott, 1986; 
EBV, Baer et al., 1984; and HCMV, Chee et al., 1990). The 
homologues are as follows:-
3.22 : Immunoblot - Rabbit_3
Extracts from cells mock-infected, or infected with 
wt or inl601 were separated by SDS-PAGE and transferred 
to nitro-cellulose strips as described. Sera from rabbit 
3 were reacted with the immobilised extracts as 
indicated. The abbreviations are as follows;
PI - Pre-immune serum
+ 2 - serum 2 months post initial immunisiation
+4 - serum 4 months post initial immunisation
T - terminal serum (7 months post initial
immunisation)

3.23 : Immunoblot - Rabbit 4
Extracts from cells mock-infected, or infected with 
wt or inl601 were separated by SDS-PAGE and transferred 
to nitro-ce1lulose strips as described. Sera from rabbit 
4 were reacted with the immobilised extracts as 
indicated. The abbreviations are as follows;
PI - Pre-immune serum
+2 - serum 2 months post initial immunisiation
+4 - serum 4 months post initial immunisation
T - terminal serum (7 months post initial
immunisation)
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HSV-2 UL2
VZV Gene 59
EBV BKRF3
HCMV UL114
A comparison of these amino acid sequences with that of 
HSV-1 UL2 is depicted in figure 3.24. From this figure it 
can be seen that there are distinct motifs which are 
strictly conserved between all five sequences. This gene is 
one of the most highly conserved genes within the 
herpesvirus group, possessing percentage identities with 
the HSV— 1 protein of 72% for the HSV—2 UL2 gene product,
42% for the VZV gene 59 product, 41% for the HCMV UL114 
gene product and 40% for the EBV BKRF3 gene product. The 
amino acid comparisons show a striking degree of 
conservation, especially towards their carboxy termini.
All the genotypic and phenotypic evidence that gene UL2 
of HSV— 1 encodes a uracil—DNA glycosylase, presented so far 
has been of a circumstantial nature. Although all the data 
indicate that UL2 encodes the uracil-DNA glycosylase, none 
of it is direct. It is theoretically possible that UL2 may 
in fact encode an activator or enhancer function, although 
there is no evidence for this. However, work by Caradonna 
et al. (1987) indicated that the uracil-DNA glycosylase 
activity detected in these assays is virus encoded, and a 
cDNA clone was isolated, corresponding to 0.065-0.080 map 
units on the HSV genome, which expresses uracil-DNA 
glycosylase activity. UL2 lies within this region, but so 
do other genes whose role in the virus replicative cycle is 
still not clear. Final confirmation of UL2 as the uracil- 
DNA glycosylase gene came with the publication of the E. 
coli uracil-DNA glycosylase DNA sequence (Varshney et al., 
1988), which was subsequent to and independent of the
3.24 Amino acid sequence comparison 
UL2 and its homologues in other human herpesviruses
This figure is a comparison of the amino acid 
sequences translated from the HSV-1 gene UL2 and its 
homologues in HSV-2 (UL2), VZV (gene 59), EBV (BKRF3) and 
HCMV (UL114), using the computer program GAP (GCG 
software, University of Wisconsin) running on a VAX 
computer. The dots are pads inserted by the computer to 
achieve optimal alignment. The numbers refer to the 
relative positions from the start of the alignment.
Position 1 is taken as the first potential methionine 
residue of the HSV-1 UL2 gene product and all other 
sequences are aligned relative to this. On the consensus 
line, dots are positions of poor conservation (residues 
common to less than two sequences or where there are two 
different pairs of identical residues), letters in lower 
case indicate where conservation is moderate (ie there is a 
single pair of identical amino acids or a group of three or 
four identical residues) and upper case letters indicate 
where the same amino acid is common to all five sequences.
HSV1 UL2 
HSV2 UL2 
VZV 5 9 
EBV BKRF3 
HCMV UL114
Cons
HSV1 UL2 
HSV2 UL2 
VZV 5 9 
EBV BKRF3 
HCMV UL114
Cons
HSV1 UL2 
HSV2 UL2 
VZV 59 
EBV BKRF3 
HCMV UL114
Cons
HSV1 UL2 
HSV2 UL2 
VZV 59 
EBV BKRF3 
HCMV UL114
Cons
HSV1 UL2 
HSV2 UL2 
VZV 5 9 
EBV BKRF3 
HCMV UL114
Cons
HSV1 UL2 
HSV2 UL2 
VZV 5 9 
EBV BKRF3 
HCMV UL114
Cons
HSV1 UL2 
HSV2 UL2 
VZV 5 9 
EBV BKRF3 
HCMV UL114
Cons
1 50
MKRACSRSPSPRRRPSSPRRTPPRDGTPPQKADADDPTPGASNDASTETR
...................................MAMKRNP SRVFCAY SKNGTH
..................... MDVS GEP TVC SNAYANEMKL SD S KDIYVLAH
51 100
PGSGGEPAACRSSGPAALLAALEAGPAGVTFSSSAPPDPPMDLTNGGVSP 
RSAAPTTHRCIAGGGRGALDAGAENTQGHPESRCFPGGRPPQTGPSWCLG
PVTKKTRKRPR GLPLGVKLDPPTFKLNNMSHHYDTETFT......
............................ MASRGLDLWLDEHVWKRKQEIGV..
.................MALKQWMLANIADNKGSLLTPDEQA...........
11.a ..anpag.klsl..p...p...t
101 150
AATSAPLDWTTFRRVFLIDDAWRPLME.PELANPLTAHLLAEYNR.RCQT
A A  FRRAFLIDDAWRPLLE . PELANPLTARLLAEYDR. RCQT
.PDSSQLDSVEVFSKFNISPEWYDLLS.DELKEPYAKGIFLEYNRLLNSG
. .KGENLLLPDLWLDFL. ..QLSPIFQ.RKLAAVIA...... CVR.RLRT
.............. RVFCLSADWIRFLSLPDHDTVLLRDTVAAVEG.ARQL
......1 ....frrvFli.dawrpll..pelanpl.a .llaeynr.rcqt
151 ‘ 200
EEVLPPREDV.FSWTRYCTPDEVRWIIGQDPYHHPGQAHGLAFSVRANV 
EEVLPPREDV.FSWTRYCTPDDVRWIIGQDPYHHPGQAHGLAFSVRADV 
EEILPSTGDI.FAWTRFCGPQSIRWIIGQDPYPTAGHAHGLAFSVKRGI 
QATVYPEEDMCMAWARFCDPSDIKWILGQDPY . HGGQANGLAFSVAYGF 
EMVYPAPEHV. HRWSYLCPPEQVRWIVGQDPYCD . GSASGLAFGTLAGR
eevlppredv.f .W t r .CtPddvrWIiGQDPYhhpGqAhGLAFsvragv
201 250
P P P P S LRNVLAAVKNC YP E ARMS GHGCLE K WARD GVLLLNT T L TVKRGAA 
PVPPSLRNVLAAVKNCYPDARMSGRGCLEKWARDGVLLLNTTLTVKRGAA 
TPPSSLKNIFAALMESYPNMTPPTHGCLESWARQGVLLLNTTLTVRRGTP 
PVPPSLRNIYAELHRSLPEFSPPDHGCLDAWASQGVLLLNTILTVQKGKP 
P P P P S LNNVFRE LART VD GF QRP AS GCLD AWARRGVLLLNT VF T W H G Q P
ppPpSLrNv.aalk..ype.r.pghGCLe.WAr.GVLLLNTtlTVkrGap
251 300
ASHSRIGWDRFVGGVIRRLAARRPGLVFMLWGTHA. Q N . AIRPDPRVHCV 
ASTSKLGWDRFVGGWRRLAARRPGLVFMLWGAHA. Q N . AIRPDPRQHYV 
GSHVYLGWGRLVQRVLQRLCENRTGLVFMLWGAHA.Q K .TTQPNSRCHLV 
GSHADIGWAWFTDHVISLLSERLKACVFMLWGAKAGDK.ASLINSKKHLV 
GSHRHLGWQTLSNHVIRRLSERREHLVFMLWGADA.HTCEYLIDRRRHLV
gShs.lGWdrfvg.VirrL.errpglVFMLWGahA.q ..ai .p d .r .HIV 
301 349
LKFSHPSPLSKVP.........FGTCQHFLVANRYLETRSISPIDWSV. .
LKFSHPSPLSKVP.........FGTCQHFLAANRYLETRDIMPITV.V. .
LTHAHPSPLSRVP.........FRNCRHFVQANEYFTRKGEPEIDWSVI.
LTSQHPSPLAQNSTRKSAQQKFLGNNHVFLANNFLREKGLGEIDWRL.. 
LKSCHPSPRNTTR....... AFVGNDHFILANAYLDTHYRETMDWRLCG
L k .sHPSPlskvp.........F g .cqHfllANrylet.g i ..idw.v..
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isolation and characterisation of inl601. When the two 
amino acid sequences (from E. coli and HSV-1) are compared, 
there are notable similarities, especially towards
their carboxy termini. Such a comparison is presented in 
figure 3.25. This comparisons shows such a high level of 
conservation (45% of the amino acids in the E. coli 
sequence have identity with the UL2 sequence) that it 
confirms that UL2 does indeed encode the uracil-DNA 
glycosy1ase.
Since publication of the DNA sequence of the E. coli 
ung gene, the sequences of two more uracil-DNA glycosylase 
genes have been published. These are from yeast, 
Saccharomyces cerevisiae (Percival et al., 1989) and from 
humans (Olsen et al., 1989). When thes-e are translated and 
the amino acid sequences are compared with HSV-1 (figure 
3.26), the same patterns of similarity can be seen as were 
observed in the comparison with the E. coli sequence 
(figure 3.25). The degrees of identity in these cases are 
37% for the yeast protein and 36% for the human. It is also 
the case that there are several motifs which are highly 
conserved between all the sequences compared. Whether or 
not these regions of strict conservation have any 
functional implications is discussed later.
The presence of this gene in all the herpesviruses 
studied so far would tend to suggest that the uracil-DNA 
glycosylase has an important function in the lytic cycle of 
these viruses. This is in contrast with the isolation of a 
virus, deficient in this function, but with growth 
characteristics unaffected by the mutation. However, it was 
the case that the isolation and characterisation of the 
mutant was performed under conditions which may not reflect 
those present in the replicative cycle of the virus in
Figure 3.25 : Amino acid sequence comparison
UL2 and E. coli ung enzymes
This figure is a comparison of the amino acid 
sequences translated from the HSV-1 gene UL2 and the E. 
coli ung gene, using the computer program GAP (GCG 
software, University of Wisconsin) running on a VAX 
computer. The dots are pads inserted by the computer to 
achieve optimal alignment. The numbers refer to the 
relative positions from the start of the alignment. 
Position 1 is taken as the first potential methionine 
residue of the HSV-1 UL2 gene product and all other 
sequences are aligned relative to this. On the consensus 
line, dots are positions where the amino acids are 
different and upper case letters indicate where the same 
amino acid is common to both sequences.
1 5 0
UL2 MKRACSRSPSPRRRPSSPRRTPPRDGTPPQKADADDPTPGASNDASTETR 
E. coli ..............................................
Cons
51 100
UL2 PGSGGEPAACRSSGPAALLAALEAGPAGVTFSSSAPPDPPMDLTNGGVSP 
E. coli ..........................................................
Cons
101 150
UL2 AATSAPLDWTTFRRVFLIDDAWRPLMEPELANPLTAHLLAEYNRRCQTE. 
E. COli ................. MANELTWHDVLAEEKQQPYFLNTLQTVASERQSGV
Cons ' ........................W  E. . .P..... L ........ Q. . .
151 200
UL2 EVLPPREDVF SWTRYCTPDEVRWIIGQDP YHHPGQAHGLAF SVRANVPP 
E. coli TIYPPQKDVFNAFRFTELGDVKWILGQDPYHGPGQAHGLAFSVRPGIAI
Cons . . .PP. . DVF . . .R.......... V . W I . GQDPYH. PGQAHGLAFSVR.
201 250
UL2 PPSLRNVLAAVKNCYPEARMSGHGCLEKWARDGVLLLNTTLTVKRGAAAS 
E. coli PPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRAGQAHS
Cons PPSL.N......N. .P......HG . LE . WAR. GVLLLNT . LTV. .G.A.S
251 300
UL2 H S RIG WD RF VG G VIRRL AARRP G L VF ML W G T HAQ . N AIRP D P RVH C VLK F 
E. coli HASLGWETFTDKVISLINQHREGWFLLWGSHAQKKGAIIDKQRHHVLKA
Cons H. . .GW. .F. . .VI..... R.G.VF.LWG.HAQ..... D. . .H.VLK.
301 344
UL2 SHPSPLS.KVPFGTCQHFLVANRYLETRSISPIDWS.V .....
E. coli PHPSPLSAHRGFFGSNHFVLANQWLEQRGETPIDWMPVLPAESE
Cons . HPSPLS F --- HF. .AN. . LE . R . . .PIDW. .V.....
Figure 3.26 : Amino acid sequence comparison
UL2 with yeast and human enzymes
The figure opposite is a comparison of the amino 
acid sequences translated from the HSV-1 gene UL2 with 
the yeast Saccharomyces cerevesiae gene and the human 
gene, using the computer program GAP (GCG software, 
University of Wisconsin) running on a VAX computer. The 
dots are pads inserted by the computer to achieve optima 
alignment. The numbers refer to the relative positions 
from the start of the alignment. Position 1 is taken as 
the first methionine residue of the yeast amino acid 
sequence and all other sequences are aligned relative to 
this. On the consensus line, dots are positions of poor 
conservation (residues different in all three sequences) 
letters in lower case indicate where two of the residues 
are identical and upper case letters indicate where the 
same amino acid is common to all three sequences.
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vivo. There are instances of mutations in HSV-1 which are 
lethal under certain circumstances but are apparently 
tolerated under others. For example in UL39, which encodes 
the RR large subunit (Goldstein and Weller, 1988), a mutant 
was isolated in which the whole of the gene had been 
deleted. The authors demonstrated that the survival of 
viral RR mutants is dependent on the state of the infected 
cells ie cell type, presence of serum and temperature. The 
authors proposed that, in this case, the effect of the 
mutation is complemented by cellular factors. Host-cell 
complementation is also a possibility in the case of 
inl601. However, the vhs function of the virus would 
suppress transcription of any endogenous uracil-DNA 
glycosylase gene and levels of uracil-DNA glycosylase 
activity in extracts prepared from mock-infected cells are 
much lower than in those prepared from cells infected with 
wt HSV-1. Given the nature of the enzyme activity, it may 
be the case that uracil-DNA glycosylase is not required in 
the normal virus lytic cycle, but that the enzyme has an 
important role in the long term stability of the virus. It 
is proposed that the primary function of the uracil-DNA 
glycosylase enzyme is in the abatement of potentially 
deleterious mutations. If this activity is abolished, the 
potential for such mutations will increase. After 
replication, the number of progeny carrying mutations will 
be elevated. However, all progeny carrying a lethal 
mutation will fail to grow (although in the short term, the 
essential function may be complemented by virus present in 
the population not carrying this mutation, these mutants 
would not replicate upon subsequent rounds of growth).
Other progeny may carry mutations in genes which are not 
required for lytic infection per se, but may have more 
subtle roles, for instance in the pathogenicity of the 
virus, or its ability to reactivate after latency. This
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would lead to a virus with reduced biological fitness. Any 
increase in the mutation rate over that observed naturally 
could have serious consequences, as the long term stability 
of the virus would be compromised. This may account for the 
apparent innocuous nature of a mutation which abolishes a 
gene with an important function.
3.3 RECOMBINANT VIRUS in!602
3.3.1 BACKGROUND
The two pathways which lead to the occurrence of 
uracil in DNA (ie misincorporation of dUTP during 
replication and in situ deamination of cytosine) have 
already been mentioned in the introduction. The effects of 
each of these pathways are minimised by distinct enzyme 
activities. Misincorporation of dUTP is suppressed by the 
dUTPase (Shlomai and Kornberg, 1978) and deamination of 
cytosine is repaired by uracil-DNA glycosylase (Lindahl, 
1976). HSV-1 is known to encode both of these enzymes 
(Preston and Fisher, 1984; Caradonna et al., 1987). Fisher 
and Preston (1986) reported construction of an HSV-1 
mutant, dut-1218, in which the dUTPase was insertionally 
inactivated. The work reported here led to the construction 
of a mutant of HSV-1 with a mutation in the gene encoding 
the uracil-DNA glycosylase. It was decided to combine these 
two mutations, into a double mutant of HSV-1 which would 
carry both lesions, and so would not induce either enzyme 
activity.
3.3.2 COTRANSFECTION AND PURIFICATION
The DNA fragment from the plasmid pJM3 which was used 
to construct inl601 was cotransfected with DNA from the
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HSV-1 mutant dut-1218, and gave rise to the mutant inl602.
As before all the blue plaques from the initial 
titration were picked and titrated.
In subsequent rounds of plaque 
purification, ten blue plaques were picked and carried 
forward. The recombinant
plaqued with an efficiency similar to wt and to inl601, 
which was included as a control. Plaque purification 
continued until all the progeny exhibited the recombinant 
phenotype. At this stage a single, isolated blue plaque was 
picked and used to generate a high-titre elite stock, 
designated inl602. This stock had a titre of 1 X 109 and 
was used in all subsequent experiments involving inl602. In 
tissue culture this virus grew as well as wt (and inl601), 
in that plaques picked from all three viruses yielded 
similar munbers of progeny (see also section 3.3.2).
Plaques from inl602 were indistinguishable from those 
caused by infection with inl601 or wt, with the exception 
that the wt did not stain blue when grown under 
X-gal.
The genome of inl602 was subjected to a restriction 
endonuclease analysis similar to that performed on inl601, 
as described in section 2.13. The restriction enzyme used
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in this analysis was Hindlll. The Hindlll restriction 
profiles of wt and inl601 have already been discussed (see 
section 3.2.1 part d and figure 3.12).
dut-1218 was constructed by inserting an 8 bp 
oligonucleotide, containing a Hindlll restriction site, 
into the Kpnl restriction site between the Kpnl fragments u 
and o. The relative positions of these sites are shown in 
figure 3.27, a Hindlll restriction map of wt, and dut-1218 
(as well as inl601 and inl602) viruses, all in the 
prototypic orientation.
The mutation is within the Hindlll c fragment in the 
prototype arrangement (c is d + m) , the d fragment in the 
II and IS l arrangements (when it is terminal) and b 
fragment in the Is arrangement (b is d + g) . 
Correspondingly, changes in any of these fragments will 
also be observed in each of the others, due to orientation 
isomerisation.
Digestion of dut-1218 with Hindlll will result in the 
truncation of the b, c and d fragments to b’ 5 , c* ’ and d ’ ’ , 
respectively. In each case this will be accompanied by the 
appearence of a novel band, N3. This is seen in figure
3.28, an autoradiograph which has restriction profiles of 
wt and dut-1218 DNA (as well as inl601 and inl602 DNA) 
digested with Hindlll.
The double mutant inl602 is predicted to carry the 
lesions from both single mutants (inl601 and dut-1218). The 
Hindlll restriction profile of inl601 has already been 
discussed (see section 3.2.1 part d ) . Thus, the predicted . 
genotypic changes present in the double mutant inl602 are 
the additive effects of those seen in both single mutants :
Figure 3.27 : Hindlll restriction maps for
w t , in!601, dut-1218 and in!602
This figure shows the .location of the inserts in the 
prototype arrangement of the genome, and the locations of 
the Hindlll sites. The LacZ insert is located within the 
i fragment and introduces two novel Hindlll sites into 
the genome. This results in the truncation of i to i’, 
and the appearence of two novel restriction fragments, N1 
and N2. i is a terminal fragment and as such is only 
present in two arrangements of the genome (prototype and 
Is). In the other two arrangements, i is incorporated 
into the e and the f fragments. Correspondingly, the 
mutation, which truncates i, will also truncate e and f, 
to e ’ and f’ , repectively, and in both cases this will 
also be accompanied by the appearence of the two novel 
fragments, N1 and N2.
The 8 bp oligonucleotide present in dut-1218 and 
inl602 also introduces a novel Hindlll site into the d 
fragment, truncating it to d ’ ’ and introducing a novel 
fragment N3. d is only present, as a terminal fragment, 
in two arrangements of the genome (II and Isl)* In the 
other genome arragements, d is incorporated into b and c. 
Consequently, the presence of the linker, which truncates 
d to d ’* and introduces the novel fragment N3, also 
results in the truncation of b and c, to £>’ * and c’ ’ , 
repectively, accompanied in both cases by the appearence 
of the novel fragment, N3.
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Fi gure 3.28 Hindlll restriction profiles of
wtt inl601, dut-1218 and inl602
Figure 3.28 is an autoradiograph of DNA from wt, 
inl601, dut-1218 and inl602 digested with Hindlll . The 
first two lanes are identical to figure 3.12. The changes 
in wt fragments brought about by this mutation are marked 
by * (ie i, e and f are truncated to i9 , e 9 and f 9 ), and 
the novel bands N1 and N2 are indicated. The third lane 
demonstrates the changes observed in the recombinant dut- 
1218. Changes in wt fragments are marked by '’ (b, c and
d are modulated to b99, c9 9 and d ’ 9), and the novel 
fragment is nominated as N3. It is predicted that inl602 
will carry the mutations from both inl601 and dut-1218, 
and this is observed. The truncated fragments from inl601 
(i9, e 9 and f* ), the truncated fragments from dut-1218 
(£>’ ’ , cr ’ and d * 9 ) and the novel bands Nl, N2 and N3 are 
all indicated.
in 1601 dUT-1218 inl602
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The LacZ insert has two Hindlll sites, separated by 3.7 
kbp, and is situated in the i fragment in the prototypic 
arrangement of the genome. The changes in i also affect the 
e and f fragments, which are brought about by 
isomerisat ion. As was stated in section 3.2.1 d, insertion 
of the LacZ fragment truncates the Hindi II i, e and f 
fragments by 2.1 kbp, to the fragments i’, e’ and f ', 
respectively, and gives rise to two novel fragments, N1 and 
N2, 3.7 and 2.A kbp in length, respectively. The presence 
of the linker truncates the Hindlll b fragment to b’ 1 ; 
truncates the c fragment with to c’’ and truncates the d 
fragment to d ’ ’. In each case, this is accompanied by the 
appearence of a novel band N3. As can be seen from figure
3.28, an autoradiograph of Hindlll digests of wtf inl601, 
dut-1218 and inl602 DNAs, all the predicted alterations are 
present.
3.3.3 PROPERTIES OF THE RECOMBINANT in!602 
i Growth
As inl602 had been constructed in a manner similar to 
inl601, it was subjected to the same phenotypic analyses as 
inl601. The first part of this was an examination of the 
growth properties of this recombinant.
 ^The one-step growth 
curve shows the development of virus infection over a set 
period of time (24 hours) from a fixed inoculum (5
Figure 3.29 : One step growth curves
Opposite is displayed the onestep growth curves 
obtained for wt, inl601, dut-1218 and inl602. The 
monolayers were infected at 5 pfu/cell and plates were 
harvested at 1, 2, 3, 4, 6, 8, 10, 12, 21 and 25 h pi,
before being titrated on confluent monolayers of BHK C13 
cells on 35 mm plates. All titrations were performed at 
370C.
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pfu/cell). This is displayed in figure 3.29. The graph 
shows that, under the conditions of the assay, growth of 
ini602 is indistinguishable from that of wt, inl601 and 
dut-1218. This result is not unexpected as neither of the 
mutations engineered into inl602 has any effect on the 
growth properties of the single mutants. However, it is 
interesting to note that abolition of both functions 
together does not restrict the growth of the virus under 
the conditions of this experiment.
ii Enzyme assays
a) Uracil-DNA glycosylase
The predicted phenotype of inl602-is that both the 
uracil-DNA glycosylase and the dUTPase genes will be 
insertionally inactivated. In order to verify that inl602 
carried the lesion in U L 2 , uracil-DNA glycosylase assays 
were performed. Extracts were prepared from cells mock- 
infected or infected with wt, inl601, dut-1218 or inl602 at 
10 h pi and assayed for uracil-DNA glycosylase as 
described. The levels of uracil-DNA glycosylase activity in 
these extracts are shown in figure 3.30. This figure shows 
a high level of uracil-DNA glycosylase activity in the 
extract prepared from cells infected with wt and from those 
infected dut-1218, the level of activity in mock-infected 
cell extract being negligible. There was no significant 
difference between the level of activity in the extract 
from cells infected with inl602 and either inl601 or the 
mock— infected extract, indicating that this virus does not 
induce uracil-DNA glycosylase activity.
Figure 3.30 Uracil-DNA glycos.ylase assays
Extracts prepared at 10 h pi were assayed for 
uracil-DNA glycosylase activity as described (Caradonna 
and Cheng, 1980). The results of these assays are 
presented graphically. The enzyme activity present in 
each extract is displayed along the ordinate axis, as 
amount of radioactivity released/mg protein. The 
activities of extracts prepared from cells mock-infected, 
or infected with wt, inl601, dut-1218 or inl602 virus are 
shown.
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b) dUTPase activity
\
As was the case for inl601, inl602 infected cell 
extracts were also assayed for dUTPase activity. However, 
in this instance the reason for doing so was to confirm 
that inl602 also carried the lesion which incapacitated the 
dUTPase gene. The extracts used in the preceding assay were 
also used in the dUTPase assays, and the results are 
displayed in figure 3.31. This figure shows that while 
inl601 has wt levels of dUTPase activity, in inl602, this 
has been abated to the levels demonstrated by the extracts 
from mock-infected cells and cells infected with dut-1218. 
This, along with the genotypic evidence displayed by the 
restriction analysis, confirms that inl602 also carries the 
lesion from dut-1218, in the gene encoding the dUTPase.
c) Other enzyme activities
In this case it was also necessary to ensure that the 
low level of uracil-DNA glycosylase activity induced in 
cells infected with inl602 was not due to a reduced level 
of infection, so the two other enzyme activities were also 
quantified. The first of these was again the HSV-induced 
alkaline exonuclease enzyme. The extracts used in the 
uracil-DNA glycosylase assays above were used in 
exonuclease assays. The level of alkaline exonuclease 
activity present in these extracts at 10 h pi is evinced in 
figure 3.32. In this case, the levels of exonuclease 
activity in the extracts from wt, inl601, dut-1218 and 
ini602 infected cells were not significantly different from 
each other, and once again the activity from the mock- 
infected extract was essentially zero. This indicates that 
the infection with inl602 was as productive as that with 
wt, dut-1218 or inl601, and the low level of uracil-DNA
Figure 3.31 : Deoxyuridine triphosphatase assays
Extracts prepared at 10 h pi were assayed for 
deoxyuridine triphosphatase activity as described. The 
results of these assays are presented graphically. The 
enzyme activity present in each extract is displayed 
along the ordinate axis, as amount of radioactivity 
released/mg protein. The activities of extracts prepared 
from cells mock-infected, or infected with wt, inl601, 
dut-1218 or inl602 virus are shown.
dUTPase assay
gg inl601 
m  dut-1218
Q  in1602
Infected cell extract
Figure 3.32 : Other enzyme assays
Extracts prepared at 10 h pi were assayed for 
alkaline exonuclease and DNA polymerase activity as 
described. The results of these assays are presented 
graphically, on graphs a and b respectively. The enzyme 
activity present in each extract is displayed along the 
ordinate axis, as amount of radioactivity released (or 
incorporated, in the case of the DNA polymerase assay)/m 
protein. The activities of extracts prepared from cells 
mock-infected, or infected with wt, inl601, dut-1218 or 
inl602 virus are shown.
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glycosylase activity shown in the inl602 infected extract 
was not due to a reduced level of infection.
The second enzyme activity which the extracts were 
subjected to was the virus induced DNA polymerase. The 
results of this assay are also presented in figure 3.32. 
Again, there was no significant difference between the 
levels of polymerase activity in the extracts infected with 
wt, dut-1218 or inl601 and those infected with inl602, The 
mock infected extract had an insignificant level of 
activity. These results corroborate those obtained for the 
exonuclease activities.
d) Time course of enzyme assays
In order to investigate the progression of infection in 
cells either mock-infected or infected with wt, inl601, 
inl602, or dut-1218, a series of extracts were prepared at 
3, 6, 9 and 12 h pi. These extracts were assayed for the 
four enzyme activities described above. The results are 
displayed in figure 3.33. In general, the time courses show 
that the four viruses assayed exhibit the spectrum of 
enzyme activities predicted from the 10 h pi assays. Again, 
there does appear to be a small lag in the levels of 
exonuclease activity induced by inl601, but this is almost 
fully corrected by 9 h pi and so is not regarded as being 
significant.
e) Radiolabelled HSV-1 induced polypeptides
In order to discern what effect (if any), the mutation 
had on the polypeptide profile of inl602, radiolabelled 
cell extracts were prepared from cells infected with wt, 
inl601, dut-1218 and inl602. As for inl601, these extracts
Figure 3.33 : Enzyme assay time courses
Extracts prepared at 3, 6, 9 and 12 h pi were
assayed for uracil-DNA glycosylase, alkaline exonuclease, 
DNA polymerase and dUTPase activity as described. The 
results of these assays are presented graphically, in 
graphs a, b, c and d, respectively. The enzyme activity 
present in each extract is displayed along the ordinate 
axis, as amount of radioactivity released (or 
incorporated, in the case of the DNA polymerase assay)/mg 
protein. The activities of extracts prepared from cells 
mock-infected, or infected with wt, inl601, dut-1218 or 
inl602 virus are shown.
Uracil-DNA glycosylase assay time course
40 -
>> .5
bO B
10 -
2 4 6 8 10 12 14
Time (hours pi)
DNA polymerase assay time course
>0
2 4 6 8 10 12 14
Alkaline exonuclease assay time course
120
100-
&
V
§ © 80- 
% o
<-> .53 S
O O 60 “
g &
<D
•S -E
13 3 
^ £ 4°-
20 -
6 8 10 12 142 4
Time (hours pi) 
dUTPase assay time course
60 -
50 -
wt
inl601 
dut-1218 
in 1602
40 -
c8 Cu 
O  bO
E 30
mi
•o
20 “
10-
2 4 6 8 10 12 14
Time (hours pi)
Time (hours pi)
Figure 3.34 : 35S-Methionine labelled HSV induced
polypet ides
Figure 3.45 is an autoradiograph of 35S-Methionine 
labelled virus induced polypeptides. There are no 
discernible differences between the hrt profile and any of 
the others, inl601, dut-1218 or inl602. Mr are as 
indicated.
wt in1601 dUT'1218 in1602
The*fragment used was the segment between the Notl site at 
position 5092 and the iicoRI site at 3280.
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were examined by polyacrylamide gel electrophoresis, the 
results of which are shown in figure 3.34. As before, there 
are no discernible differences between any of the viruses.
3.4 ATTEMPTS TO MUTATE GENE UL1
The technique of insertional mutagenesis was also used 
to investigate the function of the gene UL1 and its 
product, which has yet to be identified.
3.4.1 COTRANSFECTION AND ATTEMPTED PURIFICATION
DNA from the plasmid pJM4 was used in a cotransfection 
experiment with wt virus DNA. This initial cotransfection 
yielded only 2 blue plaques. Attempts to purify these 
recombinants failed, as no blue plaques were seen in the 
next round. Two subsequent attempts to purify the initial 2 
plaques were also unsuccessful. The cotransfection was 
repeated, but this gave only 3 blue plaques which again 
failed to purify. A third attempt, in which fresh BHK C13 
cells of low passage were used yielded 20 blue plaques. All 
of these were picked and plaque purification was attempted.
However, it quickly became apparent that 
the recombinant was again failing to purify. By the third 
round of purification, no blue plaques were detected. This 
is in contrast to what was in observed in the purification 
of the recombinants inl601 and inl602. A further two 
attempts to isolate this recombinant also failed.
There are several possible explanations why isolation 
of this recombinant was not achieved. Perhaps the most 
likely of these are either that the mutation resulted in a 
genome which was unstable (for instance due to other,
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unpredicted alterations), or that there is a stringent
requirement for the UL1 gene product in the lytic cycle of
the virus. The unexpected appearence of unpredicted, and 
potentially unstable, rearrangements in recombinants 
constructed by homologous recombination has already been 
discussed. In the case of this construction, there were no 
duplications or rearrangements in the HSV-1 sequences 
within the plasmid. Although the plasmid contained a
deletion in part of the HSV-1 sequence, the DNA used in the
cotransfection was a single segment of DNA, contiguous 
apart from the LacZ insert. It seems unlikely that this 
construct would be unstable upon cotransfection.
The fact that recombinant blue plaques were observed in 
the initial transfection would tend to support the 
suggestion that there is an absolute requirement for the 
product of UL1 in the lytic cycle of the virus.
The function of the UL1 gene product is at present 
unknown. Extensive searches for homologues in the major 
sequence databases have failed to reveal any similar amino 
acid sequences of known function and little information can 
be deduced from the amino acid sequence on its own.
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One way of potentially overcoming the problems 
associated with the mutagenesis of an essential gene is the 
construction of a cell line which expresses that gene and 
which would therefore be able to complement the function of 
its product, not expressed by the recombinant virus.
FINAL DISCUSSION
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4.1 VALIDITY OF MUTAGENESIS AND COTRANSFECTION TECHNIQUES
Insertional mutagenesis has been used as a technique 
for investigating the functional potential of genes whose 
role in the lytic cycle of the virus has not been 
established. This has led to the positive identification of 
the gene encoding the HSV-1 specified uracil-DNA 
glycosylase enzyme as UL2. In this case the assignation was 
made after construction and analysis of a mutant which 
exhibited the predicted genotype and phenotype, and was 
subsequently confirmed by amino acid sequence homology with 
published sequences from other sources. That HSV encodes 
its own uracil-DNA glycosylase enzyme was first observed by 
Caradonna et al. (1987), who reported that the gene 
encoding this function was situated between 0.065 and 0.080 
map units (mu) on the virus genome. However, inl601 is the 
first reported isolate of HSV-1 which is deficient in 
uracil-DNA glycosylase activity, due to a mutation in the 
gene UL2. When the amino acid sequence of the UL2 gene 
product is compared with amino acid sequences from uracil- 
DNA glycosylase enzymes isolated from other organisms, it 
can clearly be seen that gene UL2 encodes the HSV—induced 
uracil-DNA glycosylase enzyme. /
The second recombinant virus constructed by this 
technique was a double mutant, carrying lesions in the 
genes encoding both the uracil-DNA glycosylase and the 
dUTPase. Both of these recombinant viruses (inl601 and 
inl602) were isolated and purified at the first attempt, 
and exhibited no rearrangements in their genomes, apart 
from those predicted. This technique has also been used in 
the construction of recombinant viruses with insertions in 
other genes. The availability of a facile screening 
procedure for recombinants means that they can be
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identified and selectively purified without the need to 
screen large numbers of plaque isolates, as is often the 
case with the isolation of other types of insertion 
mutants.
The effects of such mutations on the growth properties 
of HSV-1 are dependent on the target gene and range from 
lethality (for example in the DNA polymerase gene, Purifoy 
et al., 1977) to having no apparent effect (the dUTPase, 
Fisher and Preston, 1986). Mutagenesis is a key step in the 
functional analysis of genes whose role in the replicative 
cycle of the virus is obscure. As the functions of more 
HSV-1 genes become known, the number whose products are not 
required for virus growth increases. At present, there are 
at least 19 genes in HSV-1 whose products appear to be 
dispensible for growth of the virus in tissue-culture 
(McGeoch, 1989). No doubt more will be discovered as 
functional assignments are made to the remaining genes 
whose in vivo roles are as yet unresolved.
The one case in which the technique failed was in the 
isolation of a recombinant virus carrying an insertion in 
the gene UL1 (inl603), which indicates that this gene may 
be essential for growth of the virus. However, throughout 
the attempts to plaque purify this recombinant it was 
apparent when the purification was failing.
The mutagenic technique employed to construct these 
recombinants could also be used to engineer deletions into 
target genes, in a manner analogous to that using the TK 
gene as a phenotypic marker. For instance, the entire UL2 
gene could be deleted from the plasmid pGX23, and this 
plasmid could then be used in a cotransfection experiment 
with inl601 DNA. Homologous recombination would remove the
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LacZ insert and the UL2 flanking sequences, and would yield 
clear plaques against a background of blue plaques. This 
has been performed in the construction of a recombinant 
with a deletion of the gene UL43, where the construction, 
identification and purification of the deletion mutant was 
no more difficult than that of the insertion mutant (Dr C A 
MacLean, personal communication).
4.2 GENOTYPIC CONFIRMATION OF RECOMBINANT VIRUSES
The ease with which recombinant progeny could be 
identified and purified was complemented by the utility of 
the screening procedure employed to confirm the genotypes 
of the recombinants. The restriction analysis used was 
based on the techique first described by Lonsdale (1979), 
who utilised it to discriminate between the different 
serotypes of HSV. This technique is useful not only when 
large alterations are made to the genome (ie the insertion 
or deletion of large DNA sequences) but also when smaller 
changes are made, which influence the characteristic 
restriction profiles of the virus. In the case of inl601 
both of these occurred, with the insertion of a large DNA 
fragment containing restriction sites not found in the wt 
genome. The recombinant dut-1218, on the other hand, only 
contains a small 8 bp insertion, which would not normally 
affect the restriction profile. However, the introduction 
of a novel Hindlll restriction site into the genome 
facilitated the identification of the recombinant by this 
method (Fisher and Preston, 1986).
4.3 ENZYME ASSAYS
After it had been confirmed that the genome of the 
recombinants were as expected and no other aberrations were
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present, the next step was to investigate the phenotypic 
alterations brought about by the mutations.
The results obtained from the uracil-DNA glycosylase 
assay show that mock-infected cells have a low level of 
uracil-DNA glycosylase activity. Uracil-DNA glycosylase 
appears to be ubiquitous in nature (Varshney et al., 1988) 
and the activity observed in the mock-infected extract is 
presumably due to this enzyme being present in the tissue- 
culture cells.
Caradonna and Cheng (1981) reported a six-fold increase 
in uracil-DNA glycosylase activity in HeLa BU cells 
infected with HSV-1 and a forty-fold increase in the same 
cell line infected with HSV-2. The authors could not 
account for the disparity between the serotypes, but it has 
also been observed in BHK C13 cells infected with HSV-1 and 
with HSV-2 (Dr H Rixon, personal communication). The 
results presented in this thesis demonstrate an 
approximately equivalent increase in uracil-DNA glycosylase 
activity succeeding infecting with HSV-1, at almost ten­
fold as opposed to six-fold. Both recombinants which carry 
the mutation in the UL2 gene (inl601 and inl602) have mock- 
infected levels of uracil-DNA glycosylase activity.
As stated previously, the infected cell extracts were 
assayed for three other virus-associated enzyme activities. 
The major reason for doing so was to confirm the results 
obtained from the purification of the recombinant} ie that 
infection with inl601 was as productive as with wt 
(although, the dUTPase assay was performed to confirm that 
inl602 carried the mutation in UL50). Therefore, the 
reduced levels of uracil-DNA glycosylase activity induced 
by inl601 were not a consequence of the recombinant being
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less virulent than wt.
The first of these assays was for alkaline exonuclease. 
This assay is performed at pH 9.0, which reduces any 
endogenous exonuclease activity to almost zero (Morrison 
and Keir, 1968). Under these conditions, the HSV-1 enzyme 
is still very active, inducing at least a ten-fold 
stimulation in exonuclease activity. This stimulation is 
apparent, to approximately equivalent levels, in extracts 
from cells infected with any of the four virus strains used 
in this study (ie wt, inl601, dut-1218 and inl602).
The second of these assays was for the HSV-1 DNA 
polymerase. As in the previous case, the conditions of the 
assay reduce any endogenous enzyme activity, almost to 
zero.
One other HSV-l-induced enzyme activity which was 
quantified in the course of this study was the dUTPase. The 
assay is performed at 4°C, which inhibits the host cell 
enzyme (Wohlrab et al., 1982). Like that for the uracil-DNA 
glycosylase, the dUTPase assay was performed for 
confirmation of mutant phenotypes. The extracts from cells 
infected with viruses possessing intact dUTPase genes 
induced a four-fold increase increase in the enzyme 
activity over those extracts from cells infected with 
viruses carrying the mutation in the gene encoding the 
dUTPase, which were equivalent to extracts from mock- 
infected cells.
In all cases, the four virus isolates had levels of 
enzyme activity equivalent to those predicted by their 
phenotypes. All the assays yielded results which were 
quantifiable and which were unequivocal. The lowest level
101
of virus-mediated stimulation was witnessed in the dUTPase 
assay, but in this case there was still approximately a 
four-fold increase in the appropriate extracts. This is not 
surprising as there are published examples of all the . 
assays being previously performed in HSV-infected mammalian 
cells, with satisafactory results.
4.4 THE HSV-1 ENCODED URACIL-DNA GLYCOSYLASE
The experimental data presented in this thesis 
demonstrate that the gene UL2 of HSV-1 encodes the uracil- 
DNA glycosylase activity described by Caradonna and Cheng 
(1981). A recombinant virus constructed with an insertional 
mutation in the gene UL2 fails to induce uracil-DNA 
glycosylase activity and the amino aci-d sequence of the 
protein encoded by UL2 is endowed with highly conserved 
motifs which appear to be characteristic of the enzyme.
The in vivo role of uracil-DNA glycosylase appears to 
be relatively well characterised (Lindahl, 1974), as is the 
reaction which it catalyses (Lindahl, 1976; Lindahl et al., 
1977). No function has been attributed to the enzyme other 
than excision of uracil from DNA, leaving an AP site. It is 
proposed, therefore, that the enzyme must have a similar 
role in the lytic cycle of the virus. That this gene is 
common to all the herpesviruses (and is amongst the best 
conserved genes) is indicative of the protein having a 
fundamental role throughout the evolution of these viruses. 
It is now generally accepted that this role is in the 
prevention of mutations brought about by deamination of 
cytosine to uracil.
Duncan et al. (1978) reported the isolation and 
characterisation of a uracil-DNA glycosylase—deficient
102
strain of E. coli (ung). In this strain, the rate of 
spontaneous mutations at cytosine residues was increased to 
the level observed at 5-methylcytosine residues in wt cells 
(Duncan and Miller, 1980). 5—methylcytosine residues are 
hotspots of spontaneous base substitutions (Coulondre et 
al., 1978), but are deaminated to thymine which cannot be 
removed by uracil-DNA glycosylase. Thus, in an ung mutant, 
unmodified as well as modified cytosine residues become 
hotspots of mutation. It would be interesting to discover 
if inl601, which is deficient in uracil-DNA glycosylase 
activity, has an elevated amount of uracil in its DNA, due 
to spontaneous deamination of cytosine which will not be 
corrected. Presumably the DNA polymerase would pair the 
uracil with adenine upon the next round of replication, 
leading to a G.C to A.T transition mutation. It is not 
known to what extent this type of mutation occurs in ung 
mutants. Attempts were made to quantitate the levels of 
uracil present in the genomes of all four virus strains 
used in this study. Analysis using paper electrophoresis 
and chromatographic separation by HPLC after both formic 
acid digestion of virus DNA and enzymatic digestion with 
nuclease and phosphodiesterase were attempted. 
Unfortunately, none of these techniques gave satisfactory 
results in the time available and so cannot be included in 
this thesis.
It seems unlikely that the uracil-DNA glycosylase has 
potential as a possible target for anti-viral chemotherapy. 
Abolition of the function appears to have no detrimental 
effect on the infectivity or replication of the virus. 
Whether the mutation affects the long-term stability of the 
virus remains to be determined.
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4.5 THE RECOMBINANT in!602
The recombinant inl602 carries insertional mutations in 
two genes involved in DNA metabolism, namely the uracil-DNA 
glycosylase and the dUTPase. The significance of the former 
has already been discussed (section 4.4). The HSV-encoded 
dUTPase is also dispensible for growth in tissue—culture 
(Fisher and Preston, 1986) but is responsible for 
preventing misincorporation of dUMP into DNA during 
replication (Shlomai and Kornberg, 1978).
Although it is known that the HSV-1 dUTPase is not 
essential for growth of the virus, it has been proposed
I
that this enzyme might still be considered as a possible 
anti-viral target (Williams, 1988). Plaque reduction assays 
on HSV-1 dUTPase mutants, using synthetic nucleoside 
analogues, suggested that certain compounds, for example 5- 
fluoro-2’—deoxyuridine, can inhibit the HSV-1 dUTPase 
enzyme. This leads to an increase in the concentration of 
dUTP, which in turn may result in more dUTP being 
incorporated into the DNA. The action of uracil-DNA 
glycosylase on this DNA with an increased uracil content 
could result in fragmentation of the DNA, as the repair 
processes initiated by the enzyme are activated. In E. 
coli, dut mutants, which do not synthesise dUTPase, fail to 
grow exponentially, become filamentous at temperatures 
above 25oC and exhibit a hyper-rec phenotype (Warner et 
al., 1981). These mutants were previously named sof 
mutants, because they accumulate short Okazaki fragments 
(Konrad and Lehman, 1975). This fragmentation is also 
recognised as being due to the action of repair processes 
initiated by uracil-DNA glycosylase. It is interesting to 
note that, by itself, incorporation of uracil instead of 
thymine in DNA does not appear to be markedly mutagenic. E.
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coli mutants deficient in both dUTPase and uracil-DNA 
glycosylase (dut ung) grow exponentially, do not become 
filamentous and are not hyper-rec. Thus the phenotypic 
alterations apparently due to abolition of the dUTPase 
activity are in fact due to the processes of repair. The 
first step in this pathway is the excision of the uracil by 
uracil-DNA glycosylase, and abolition of this function 
prevents these processes from proceeding. These mutants 
retain their viability even when as much as 15-20% of their 
thymine residues are replaced by uracil (Warner et al., 
1981).
It seems likely, therefore, that the uracil-DNA 
glycosylase would not be a potential target for anti-viral 
chemotherapy, even when combined with the dUTPase. In fact, 
it would appear that any possible anti-viral effect brought 
about by mutation to the dUTPase, may in fact be reduced by 
a simultaneous mutation in the uracil-DNA glycosylase, as 
is the case in the dut ung E. coli.
Like inl601, nothing is known about the composition of 
the DNA of inl602. It is a possibility that inl602 will 
also contain uracil as a result of both lesions. This would 
lead to G.U base pairs due to the absence of uracil-DNA 
glycosylase activity and A.U pairs due to the absence of 
the dUTPase function. Attempts made to quantitate the 
amount of uracil in the genome of this virus were also 
unsuccessful.
4.6 ATTEMPTS TO MUTAGENISE THE GENE UL1
One limitation of the mutagenesis technique employed in 
this study is that it cannot be used to engineer mutations 
in genes whose products are essential in the norma1 lytic
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cycle of the virus. It is proposed that the product of the 
gene UL1 is essential for normal growth of the virus. 
Research by another group working on this gene has also 
indicated this (D. Johnson, personal communication). Perry 
(1986) suggested that the protein may be membrane 
translated, as the amino terminus of the protein is 
strongly hydrophobic. Apart from this analysis, little is 
known about the proposed product of UL1. Searches of the 
NBRF and Swissprot protein databases, using Wordsearch, a 
program which can search databases for conserved amino acid 
motifs, have produced no evidence of a homologue .of known 
function for the product of this gene.
One piece of information which may concern the UL1 gene 
and its product is the report by Little- and Schaffer
(1981), that a syn locus maps to this region of the genome, 
map coordinates 0.040 to 0.064. However, the authors were 
not able to assign this lesion to a specific gene.
4.7 FUTURE PROSPECTS
Now that these recombinants have been constructed, 
there are a variety of studies which should be performed 
upon them. One of the most important of these is the 
determination of the amount of uracil present in the 
genomes of these viruses, and whether this changes after 
passage. Chromatographic separation of enzymatic digestion 
products, for example by HPLC, would provide a measure of 
the amount of uracil present in the genomes.
Because of the nature of the mutations they contain, it 
may be the case that these recombinants will exhibit an 
increased mutation frequency, relative to wt. It would be 
interesting to see if this was the case, after serial
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passage of the virus in tissue culture. HSV-1 has a high 
G+C content (68.3%, McGeoch et al., 1988), therefore there 
are many cytosine residues which could potentially be 
deaminated. The phenotype of these viruses dictates that 
the resulting defects would not be corrected. The DNA of 
these mutants, after serial passage, could be examined 
directly, for example by restriction enzyme analysis. 
Alternatively, a way to screen for such mutants on a 
phenotypic basis would be to look for mutations in the DNA 
polymerase gene. It has been reported that mutations in the 
pol gene can confer resistance to antiviral agents based on 
DNA polymerase substrate analogues (Hay and Subak-Sharpe, 
1976; Honess et al., 1984).
As the functions of more HSV-1 gene products become 
known, it is to be expected that some will be essential for 
growth in tissue culture and, by definition, will be 
difficult to study by mutagenesis. This has been the case 
with the UL 1, the product of which may be essential for 
lytic infection and replication of HSV-1. Potentially, 
these genes are very important, as there is much active 
research into possible antiviral therapeutic agents. Any 
function which is indispensible for virus growth and 
proliferation is a valid target for such analysis. One way 
round the requirement for a particular function which has 
been incapacitated is to find a cell type which can provide 
the necessary function in trans. This can be an unmodified 
cell line which fortuitously compensates for the essential 
function, as is the case for mutants isolated with a 
deficiency in the RR large subunit which can grow in some 
cell types but not others (Goldstein and Weller, 1988). 
Alternatively, a cell line may be isolated which expresses 
the part of the HSV-1 genome in which the mutated gene 
lies. This is achieved by transfecting a specific
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restriction fragment of HSV-1 into the cells, which it is 
hoped will integrate into the cellular genome and be 
expressed. This can then be cotransfected with wt HSV— 1 DNA 
and the mutating plasmid DNA and the intact cellular gene 
will complement the function which has been inactivated in 
the mutant. As the product of UL1 appears to be absolutely 
required for growth, it is a feasible target for such a 
study.
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